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Cancer is one of the leading causes of death worldwide and of all the cancer related deaths 
occurring worldwide, 70% are in low and middle income countries.  In Africa, the disease kills 
more people than HIV, TB and malaria combined. In Kenya, cancer continues to claim millions 
of lives. The poor prognosis of cancer in Kenya is due to a lack of facilities for diagnosis and 
treatment which is further worsened by poor access to these facilities resulting in the majority of 
Kenyans turning to herbal medicine for treatment. Natural products have been an invaluable 
source of therapeutic drugs with 60% of cancer chemotherapy in the market today being plant-
derived drugs.  However, challenges such as drug toxicity and resistance facing chemotherapy it 
has become imperative to find alternate drugs with improved specificity and efficiency. The 
current study focuses on two plants, Moringa oleifera and Prunus africana which are widely 
used in Kenya for cancer treatment and are reputed to cure various malignancies. There is need 
to obtain insight into the phytochemistry of these plants and their supposed activity as well as 
bioprospecting for potential novel anticancer drugs. In this work, the phytochemistry, in-vitro 
cytotoxicity and apoptosis induction activity of isolated phytocompounds on mammalian 
colorectal adenocarcinoma (Caco-2), hepatocellular carcinoma (HepG2) and the non-cancer 
human embryonic kidney cell (HEK293) cell lines are reported. Phytochemical studies using 
different chromatographic and spectroscopic techniques led to the isolation of six compounds, 
namely quercetin-3-O-glucoside, 4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl 
isothiocyanate, lutein, β-sitosterol, β-amyrin and sitosterol-3-O-glucoside. These were 
successfully purified and their structures were confirmed using spectroscopic techniques. GC-
MS profiling of P. africana extract revealed 9 compounds of interest. Four of the purified 
compounds were tested for potential anticancer activity using in-vitro cytotoxic and 
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immunofluorescent techniques. The MTT cell proliferation assay was used to test for cytotoxic 
activity and dual staining using acridine orange and ethidium bromide were used to study 
apoptosis. A concentration dependent cytotoxicity was observed across all cell lines with low 
activity on the non-cancer HEK293 cell line. 4-(β-d-glucopyranosyl-1→4-α-l-
rhamnopyranosyloxy)-benzyl isothiocyanate was the most cytotoxic compound tested across all 
cell lines based on IC50 values with β-amyrin being the least cytotoxic. All compounds tested 
exhibited higher cytotoxic activity on the colorectal adenocarcinoma (Caco-2) cell line than the 
hepatocellular (HepG2) cancer cell line. Further investigation on possible mechanisms of action 
using immunofluorescent studies confirmed apoptosis as one of the modes of cell death which 
was also selective to cancer cells. Higher apoptotic indices were observed on the cancer cell lines 
than the non-cancer cell line.  The findings in this study will contribute to the existing knowledge 
on natural products and their anticancer activity and will provide a basis for development of 
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According to the World Health Organization, cancer is a leading cause of death worldwide and is 
fast becoming an epidemic. According to Bray et al (2013), about 7.6 million people worldwide 
died from cancer in 2008 and approximately 70% of these deaths occurred in low and middle 
income countries. These deaths are predicted to continue rising. Cancer may be defined as an 
abnormal growth of cells that invade and spread to other tissues and organs in the body by a 
process referred to as metastasis. Apart from a genetic predisposition to specific types of cancers 
such as BRCA1 breast cancer, chronic viral infections, toxic chemicals from the environment, 
exposure to ultra violet radiation, contamination from food such as aflatoxins from grain (Danaei 
et al., 2005; Boffetta et al., 2009; Hamilton et al., 2000; Metcalfe et al., 2004) can all cause 
cancer. The high prevalence of communicable diseases such as HIV leads to immune 
suppression which is a risk factor for cancer (Silverberg et al., 2011). Genes plays a major role in 
cancer in that it can be inherited. Cancer occurs across all age groups but commonly manifests in 
older people due to an accumulation of risk factors with time. Cancer has existed for thousands 
of years and, previously, the only form of treatment came from natural products. This is well 
documented in ancient medical literature and in several historical texts (Cragg and Newman, 
2013; Balandrin et al., 1993).  
Cancer has only become well understood in the last century and knowledge of its epidemiology 
continues to be studied. Cancer is a multi-stage disease that starts with a mutation in the cells’ 
DNA. This modification in the DNA of a cell can alter or damage critical genes which are not 
repaired by the cells’ repair mechanisms. DNA replication of these damaged genes occurs 
2 
 
followed by cell division making the mutation permanent. Once the damage has occurred, the 
cell breaks free from normal control processes and replicates profusely, growing into a mass of 
cells. This mass of cells can be transported through the blood stream to form cancers in other 
parts of the body by the process of metastasis. Because of the complexity and number of 
molecular players involved in the cell cycle and the development and progression of cancer, it 
becomes a difficult disease to control. It is a culmination of defects in the cell cycle that are part 
of normal cell processes that eventually lead to tumor development. 
The most common cancers in Africa are cancers of the cervix, liver, breast, prostate, Kaposi 
sarcoma and Non-Hodgkin’s lymphoma, with the latter two occurring mostly in the HIV 
population. The most prevalent cancer in the world is lung cancer followed by breast cancer with 
1,608,000 and 1,384,000 new cases, respectively, diagnosed in 2008 as shown in Figure 1.1. 
 




In Africa, non-communicable diseases like cancer, diabetes and hypertension have become a 
major public health concern. According to the International Agency for Research on Cancer, 
715,000 new cancer cases and 542,000 cancer deaths were reported in Africa in 2008. However, 
this continues to be given a low public health priority in the continent due to the burden of 
infectious diseases agenda taking center stage and the lack of proper awareness. This has been 
further influenced by the fact that the continent is still dealing with other pressing healthcare 
problems such as HIV and TB (Parkin et al., 2003). 
The incidence of cancer in Kenya alone has increased in recent years, being the third most 
common cause of death after infectious and cardiovascular diseases (Torrorey et al., 2014). 
Cancers commonly prevalent in developed countries are now on the rise in other countries. This 
is attributed to the changing lifestyle in these areas as people continue to embrace westernisation 
especially when it comes to nutrition. This adoption of western cultures has seen an increase in 
colorectal/stomach, liver and breast cancer (Jamison et al., 2006). In Kenya, cervical and breast 
cancer was the leading cause of death in women in 2008 and Kaposi’s sarcoma and prostate 
cancer in men (National guidelines for cancer management Kenya, 2013). Kenyans in rural areas 
have poor access to health care facilities and are unable to afford modern medicine, resulting in 
them turning to traditional herbal medicine and herbalists for treatment (Wagate et al., 2008; 
Kigen et al., 2013). In Kenya, the majority of people in the rural and urban areas use traditional 
medicine to treat illnesses ranging from stomach ache to HIV and cancer. This herbal medicine is 
usually sold in the form of dry, ground plant material or as herbal tonics. Herbalists prepare 
different concoctions of the bark, root and leaves from selected plants that are reputed to have 
healing properties. Herbal medicine is generally bought from traditional medicine men in rural 
areas as ground plant material or on the streets as herbal tonics. Two of the most commonly used 
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plants for treatment of cancer and other malignancies in Kenya are Prunus africana and Moringa 
oleifera (Ochwang’i et al., 2014; Muriuki et al., 2012). These trees are widely grown in the 
country. 
 Cancer treatment includes a combination of surgery, radiation and chemotherapy. Treatments 
can be successful when the cancer is still at its early stage. Medicinal plants have been used for 
thousands of years to treat and prevent a number of diseases in many cultures across the globe, 
including cancer. Knowledge of traditional medicine is passed down from one generation to 
another and most, if not all, traditional doctors have no knowledge of the bioactive compounds 
present in the plants responsible for its activity. 
The activity of most plants against diseases is due to bioactive compounds found within the 
plants. A large number of plant bioactive compounds have been isolated and are commercially 
available as drugs. The study of plant bioactive compounds especially with regards to anti-cancer 
agents started in the early 1950s. Some examples of plant-derived compounds that are currently 
in use as cancer drugs are vinblastine, vincristine and campothecin derivatives which are used in 
combination with other drugs against a variety of cancers (Cragg and Newman, 2013). The 
National Cancer Institute has collected around 35,000 plant samples from 20 countries and has 
screened 114,000 extracts for anticancer activity (Shoeb, 2006). Among the widely used 
anticancer drugs between 1983 and 1994, 60% are of natural origin, as either derivatives of 
natural products or synthetics based on natural products (Bhanot et al., 2011). These natural 
products include plants, marine organisms and micro-organisms (Cragg and Newman, 2013). 
Natural compounds are extracted from plants using organic solvents of varying degrees of 
polarity, with non-polar compounds being extracted by non-polar solvents, e.g. hexane and 
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dichloromethane, and the more polar compounds being extracted by polar solvents e.g. methanol, 
ethyl acetate or water. Purification of compounds is carried out by various chromatographic 
techniques and identification is done by extensive spectroscopic analyses using gas 
chromatography-mass spectroscopy (GC-MS), Nuclear Magnetic Resonance (NMR), Ultra-
Visible spectroscopy (UV-Vis) and Infra-Red spectroscopy (IR). 
Cancer chemotherapy is faced with many challenges among which are non-specificity, drug 
toxicity and multi-drug resistance. A large number of drugs (Table 1.1) approved by the Food 
and Drug Administration (FDA) are effective but many lack specificity leading to significant 
toxicity and side effects that culminate in the patient dying from these effects rather than from 
the tumour itself. This has led researchers to focus on finding alternative drugs and ways of 
improving on existing drugs especially with regards to the drugs toxicity. Nature’s biological and 
chemical diversity have provided the opportunities to discover novel compounds with potential 
therapeutic uses. 
Table 1.1: Some chemotherapy drugs and their modes of action (Payne and Miles, 2008) 
TYPE MODE OF ACTION EXAMPLE 
Alkylating agents Damages the DNA  Chlorambucil, Busulfan, 
Antimetabolites Damages DNA and RNA 5-Fluorouracil, 





Inhibits the activity of topoisomerase Etoposide, Topotecan 
Platinum complexes Inhibits DNA, RNA and protein synthesis. Oxaliplatin, Cisplatin 
Taxanes Binds to tubulin and inhibits depolymerisation  Paclitaxel, Docetaxel 
Tubulin interactive 
agents 
Binds to tubulin preventing polymerisation 






It is thus important to study the phytochemistry of these plants and to ascertain whether 
compounds present in these plants show promise as anticancer agents that can be developed into 
new anticancer drugs.  
1.2 Apoptosis as a target for chemotherapy 
The uncontrolled cell division in cancer is due to interference in the cell cycle.  This link 
between the cell cycle and cancer has led to the idea that cancer is a cell cycle disease, since the 
over-proliferation of cells is due to a reduction in sensitivity to signals (proto-oncogenes / tumour 
suppressor genes) controlling normal cell proliferation. This can be due to internal or external 
factors which can cause loss of function or gain of function mutations (Collins et al., 1997). If 
DNA is damaged at any stage of the cell cycle the damage is repaired by the cell’s repair 
mechanisms or the cell undergoes apoptosis. Otherwise the mutation is passed on to daughter 
cells which may grow to become cancer cells (Boik, 2001). 
Apoptosis is programmed cell death and is vital for maintaining cell populations and tissue 
homeostasis. Unlike necrosis, apoptosis acts on individual cells without causing rupture that 
could lead to inflammation, (Jurisic and Bumbasirevic, 2008). Apoptotic cells are rapidly 
phagocytosed and cause no inflammation unlike necrotic cells which lose membrane integrity 
and release the cytoplasmic contents into the surrounding tissue, causing inflammation (Elmore, 
2007). Apoptosis can be activated through the extrinsic pathway (death receptor pathway) or the 
intrinsic (mitochondrial mediated) pathway (Arunakaran et al., 2012). The extrinsic pathway is 
activated when a ligand binds to tumour necrosis factor (TNF)-related apoptosis inducing ligand 
or apoptosis-mediating surface antigen (FAS) receptors which lead to activation of the initiator 
caspases. Initiator caspases 8, 9 and 10 lead to activation of the effector caspase 3, which results 
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in activation of the Bcl-2 family proteins. Bcl-2 family proteins consist of the pro-apoptotic 
(Bax, Bak, and Bid) and anti-apoptotic (Bcl-2, Bcl-XL) proteins (Cerella et al., 2014). The 
mitochondrial pathway is activated by external stimuli, including toxins and radiation, that lead 
to DNA damage causing activation of the Bcl-2 family proteins, in particular, Bid, which leads to 
the formation of the apoptosomes and activation of caspase 9. Cytotoxic agents, including 
natural products are suggested to induce apoptosis through the mitochondrial pathway (Pedersen 
et al., 2002). The tumour suppressor gene p53 regulates the expression and its mutation in most 
cancers and is linked to their resistance to apoptosis. Natural compounds are known to induce 
apoptosis by up-regulation of pro-apoptotic proteins and down-regulation of anti-apoptotic 
proteins. Some chemotherapy drugs in the market act by inducing apoptosis in cancer cells 
through various mechanisms. 
 1.3 Use of traditional medicine for cancer treatment 
Despite the many advanced forms of cancer therapy in use today, traditional medicine continues 
to take center stage in the fight against cancer (Butler, 2004). Herbal medicine is used worldwide 
by millions of people who use it in different ways for prevention and treatment of a plethora of 
illnesses.  In Africa, it is widely used due to poverty, poor access to health facilities and cultural 
beliefs. In Kenya, 90% of the population use herbal medicine in different forms (Kareru et al., 
2007). This is mainly due to poor access to health care facilities and their further influence by 
cultural beliefs. However, the majority of Kenyans also believe in the effectiveness of traditional 
medicine and use it in combination with prescribed drugs to treat chronic illnesses. Herbal 
medicine has been recommended by medical practitioners for patients who have become 
resistant to chemotherapy and radiation, and to the weak and elderly who may not be able to 
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handle the chemotherapy side effects (Singh et al., 2003). Using herbal medicine in combination 
with modern chemotherapy may lead to drug interactions, making the conventional drug more or 
less effective. It is thus important to study the chemical constituents of medicinal plants used and 
how they may interact with conventional medicine. In Kenya, illnesses such as diabetes, 
hypertension, cancer, HIV/AIDS and infertility (Kigen et al., 2013) are treated using herbal 
medicine, since it can be easily accessed from herbalists who also provide advice on its use and 
dosage (Figure 1.2). 
A number of plants used as herbal medicine have provided useful drugs in medicine. Atemesia 
annua used traditionally in the treatment of malaria has been studied and the compound atemesin 
was found as the active compound. The rhizome of Hypoxis hemerocallidea in southern Africa is 
used in the treatment of urinary tract infection. It contains a diglucoside compound called 
hypoxoside which, upon hydrolysis, produces the aglycone rooperol which is cytotoxic to certain 
cancer cells and is currently undergoing clinical trials (Drewes, 2012). 
 




1.4 Natural products in drug discovery 
The need to study natural products as possible anticancer agents is important since they have 
been used for thousands of years for the treatment and prevention of many diseases and many 
have been proven to be effective. Moreover natural products have been and continue to be 
invaluable sources of drug leads and models for the design and synthesis of novel drugs. Natural 
products and their derivatives represent 60% of all drugs currently in clinical use (Cragg and 
Newman, 2005). These products, i.e. herbs, spices, fruit and vegetables, are used in various 
formulations, viz. tonics, powder, extracts or cooked as food to prevent, treat or cure diseases. 
Recently, the use of plants as therapeutic agents has involved the isolation of active compounds. 
Drug discovery is an extensive and complex process that is multidisciplinary. The development 
of a drug from the laboratory to the patient requires the involvement of ethnobotanists, natural 
product chemists, pharmacologists and clinicians. This process commences with the 
identification of a plant of interest followed by the isolation and purification of the active 
compounds through bioassay-guided fractionation. In vitro, followed by in vivo studies, are 
carried out, and those compounds that successfully pass this stage move on to clinical trials. This 
process could take 10 years or more. Despite the recent shift of drug discovery to molecular 
modelling and combinatorial chemistry, natural compounds remain the single most important 
source of drug leads and serve as starting points for semi-synthetic drugs (Balunas and Kinghorn, 
2005).  In the continued fight against cancer, there is a need for more efficient drugs with 
reduced toxicity, which is a major stumbling block in chemotherapy. The study of the 
phytochemical composition of these plants is, therefore, important to enlighten the public on the 
safety and efficacy of herbal medicine, and also for researchers to develop new and improved 
therapeutic agents. This can be accomplished through the isolation of the active compounds 
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directly from natural compounds, synthesis of compounds based on the structure of natural 
compounds or through synthesis of semi-synthetic compounds from natural compounds. 
Isolation of bioactive compounds began in the early 19th century and since then hundreds of 
clinically active compounds have been isolated. The plant kingdom has provided us with 
compounds, mainly secondary metabolites with diverse chemical structures, some of which serve 
as starting points for synthetic and semi-synthetic drugs. Some of these will be discussed below. 
1.5 Plant secondary metabolites 
Plant secondary metabolites (PSM) are phytochemicals produced mainly for chemical defense 
against attack by animals and insects, microorganisms (fungi and bacteria) and defense against 
other plants competing for nutrients and light but can also serve as a form of chemical store for 
the plant. These metabolites may or may not be produced by elicitation. An example is the case 
of vinca alkaloids where fungal proteins trigger increased synthesis and accumulation of the 
alkaloids (Nagle et al., 2006). PSM may have nutritional value but many are anti-nutritional 
(Acamovic & Brooker, 2005). PSMs are grouped into many classes and can be divided into two 
main groups i.e. those with nitrogen (N) and those without nitrogen as shown in Table 1.2 below. 
Table 1.2: Classification of plant secondary metabolites (Acamovic and Brooker, 2005) 









1.5.1 Natural compounds containing Nitrogen 
1.5.1.1 Alkaloids  
Alkaloids are low molecular weight nitrogenous compounds that are produced as the plants 
defense against pathogens and herbivores. An example is nicotine from tobacco which was one 
of the first insecticides used. Alkaloids have been used for 1000s of years in medicine and are 
widely distributed in the plant kingdom (Roberts and Wink, 1998). In 1200 BC in the Middle 
East, they used Opium latex (Papaver somniferum) as a painkiller. This latex contains the 
alkaloids morphine and codeine (Figure 1.3) which are used presently in medicine as strong 
analgesics (Balandrin et al., 1993).  
 
Figure 1.3: Structure of morphine and codeine (Morphine R=OH, Codeine R=OCH3) 
Alkaloids are not only found in plants, but also in frogs, ants, bacteria, and fungi. Quinine is an 
antimalarial drug that was isolated from Cinchona officialis but can also be found in other plants. 
Sanguinarine (Figure 1.4) is an antibacterial and antiplaque chemical used in toothpaste and was 
isolated from Sanguinaria canadensis. It has been reported that this compound exhibits 
anticancer potential by inducing apoptosis and cell cycle arrest at different phases, in a number 
of cancer cell lines. Other alkaloids with similar effects are piperine from Piper nigrum and 











Figure 1.4: Structure of sanguinarine 
Vinca alkaloids, vincristine and vinblastine, were among the first natural compounds to be used 
clinically as anticancer drugs (Cragg and Newman, 2005) and have become lead compounds for 
anti-cancer drug development. 
1.5.1.2 Glucosinolates and Isothiocyanates 
Glucosinolates are compounds commonly found in the family Cruciferae with over 100 being 
identified (Wu et al., 2009). The basic structure of a glucosinolate comprises of a β-D-
thioglucose group, a side chain and a sulphonated oxime (R-C(=N-O-SO3-)-S-β-D-Glucose). 
They are hydrolysed by the enzyme myrosinase to form thiocyanates, isothiocyanates (R-S-C≡N) 
or nitriles (Verhoeven et al., 1997) (Figure 1.5). This enzyme occurs mostly outside the plant cell 
wall but also in the intestinal micro flora, and only comes into contact with glucosinolates during 


























Figure 1.5: Hydrolysis of Glucosinolates to isothiocyanates by myrosinase 
Studies suggest that isothiocyanates have the ability to prevent carcinogenesis through 
modulation of biotransformation enzymes (Zhang, 2011; Royson et al., 2015). DNA can be 
damaged by many agents such as reactive oxygen species and electrophiles which are activated 
by phase 1 enzymes and inactivated by phase 2 enzymes. The primary mode of action is 
suggested to be inactivation of phase 1 (cytochrome P450) enzymes by competitive inhibition or 
covalent modification (Verhoeven et al., 1997) and induction of phase 2 enzymes. 
1.5.1.3 Cyanogenic glycosides 
These compounds are the most commonly found naturally occurring nitriles and are widely 
distributed in higher plants, insects, bacteria and fungi (Vetter, 2000). Plants that have 
cyanogenic glycosides (Figure 1.6) include sorghum, cassava, passion fruit, lotus and plants of 
the Prunus species. Their role in plants is to serve as protection from predators and also as a 












These plants can be toxic to humans if the concentration of the glycoside is high. This is because 
cyanogenic glycosides release HCN on treatment with dilute acids or hydrolytic enzymes (Conn, 
1969). HCN is toxic to many organisms and acts by inhibiting the activity of many enzymes by 
binding to the metal functional group. Amygdalin, a common cyanogenic glycoside, is found in 
members of the Prunus species. Chang and co-workers (2006) established that amygdalin 
















Figure 1.7: Chemical structure of Amygdalin 
1.5.2 Natural compounds not containing Nitrogen 
1.5.2.1 Terpenoids 
Terpenoids belong to the large group of phytochemicals commonly found in plant essential oils 
forming the largest class of plant natural products. They are also known as isoprenoids because 
their structure is based on a number of isoprene units (Figure 1.8). They are further classified 
into different groups according to the number of isoprene units and carbon atoms. Table 1.3 






Figure 1.8: Chemical structure of an isoprene unit 
Table 1.3: Classes of Triterpenoids 
Terpene Isoprene 
 























Some monoterpenes such as thymol and carveol are reported to possess antitumour activity 
against animal and cell models viz. MCF-7 (human breast adenocarcinoma) and P-815 (murine 
mastocytoma) cells (Jaafari et al., 2012). Phytosterols have been reported to inhibit tumour 









Flavonoids are polyphenolic compounds that form an important part of the human diet. They are 
present in many dietary plants especially in the fruits and leaves. Flavonoids are made up of a 
common phenylbenzopyrone structure (C6-C3-C6) (Figure 1.9). 
O
 
Figure 1.9: Basic chemical structure of a flavonoid 
Flavonoids are classified according to their chemical structure and the substitutions and opening 
of the pyran ring. The major classes include: flavanols, flavonols, flavones, flavonones, 
anthocyanidins (Figure 1.10), isoflavones, dihydroflavonols and chalcones. Over 4000 different 
types of flavonoid compounds have been identified and more continue to be identified (Cook and 
Samman, 1995). 
Flavonoids exist mainly as glycosides as this increases their polarity which is necessary for their 
storage in the plant cell vacuoles. 
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Flavonols                         
O
OH   Flavan-3-ol 
Anthocyanidins 
Figure 1.10: Some examples of flavonoids 
Flavonoids have been found to reduce the risk and proliferation of cancer. Studies have shown 
that people with high intake of plant food containing flavonoids have a reduced risk of certain 
cancer types (Kanadaswami et al., 2005). In vitro studies have demonstrated the cytotoxicity of 
various flavonoids to different human cancer cell lines including MCF-7 , HL-60 (leukemia), 
HT-29 (colon adenocarcinoma) and A-549 (lung carcinoma) (Ren et al., 2003; Russo et al., 
2012). Research has shown that plant flavonoids induce p21 in A-549 cells, resulting in growth 
arrest and apoptosis. Its antioxidant activity induces transcription of the p21 protein without the 
need of p53, a common tumour suppressor protein, which is inactivated in 50% of tumours 
(Galati and O’Brien, 2004). 
1.6 Plant-derived anticancer drugs and their mechanism of action 
Since 1961, several phytocompounds have been approved as anti-cancer drugs (Demain and 









compounds or derivatives of it (Cragg and Newman, 2005). With the discovery and development 
of the vinca alkaloids vincristine and vinblastine from Catharanthus roseus, the National Cancer 
Institute (NCI) launched a collection and screening programme in 1960. This led to the isolation 
of new cancer drugs viz. taxanes and campothecins which were effective in killing a wide range 
of cancer cells. Taxol (paclitaxel) was isolated from the bark of Taxus brevifolia and is used in 
treatment of breast, ovarian and lung cancer. Clinically active agents that originated from 
campothecin (Figure 1.11) and isolated from Campotheca aciminate are Topotecan and 
Ironotecan (Saklani and Kutty, 2008). These are used in the treatment of lung, ovarian and 
colorectal cancers. Etoposide (Figure 1.11) and tenoposide used in the treatment of bronchial and 
testicular cancers are semi-synthetic derivatives of epipodophyllotoxin which was isolated from 
the roots of Podophyllum peltatum and Podophyllum emodi. Others include Homoharringtonine, 
a clinically active agent against leukemia isolated from Cephalotaxus harringtonia (Chin et al., 
2006) and Elliptinium from Bleekeria vitensis which is used in the treatment of breast cancer 
(Shoeb, 2006; Cragg and Newman, 2005). 
(1)              (2) 
Figure 1.11: Chemical structures of Etoposide (1) and Campothecin (2) 
Several plant compounds have been isolated in recent years and these together with their 



















Flavopiridol (Figure 1.12), a synthetic flavone, is in phase 1 and 2 clinical trials in combination 
with other chemotherapy drugs for the treatment of a wide range of tumours. Its structure is 
based on an alkaloid, rohitukine, which was isolated from Dyxoxylum binectariferum (Shoeb, 







Figure 1.12: Chemical Structure of Flavopiridol 
 
Combrestatins isolated from the South African Combretum caffrum are in phase 1 clinical trials 
(Nathan et al., 2012). Several derivatives have been developed from this compound e.g. 
combrestatin A-4, which has been reported to damage the vasculature of cancerous tumours. 
A pentacyclic triterpine betulinic acid isolated from the Betula species is reported to have anti-
inflammatory and anti-retroviral activity and has shown potential anticancer activity as well 
(Shoeb et al., 2006). It is still in pre-clinical trials. Triterpenes, oleanolic and ursolic acid, 
commonly found in many plants, have been reported to possess weak anti-tumour activity.  
Analogs have been synthesised from these compounds leading to the development of 2-cyano-
3,12-dioxoolean-1,9-dien-28-oic acid (CDDO) (Figure 1.13) which has shown activity over a 
wide range of tumours (Cragg and Newman, 2005). Others include ixabepilone from Soragium 








violaceum which has just been introduced into the market for the treatment of non-Hodgkins T-
cell lymphoma (Gordaliza, 2007). 
 
Figure 1.13: Chemical structure of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO) 
Most cancer drugs including some natural compounds act at a certain point in the cell cycle. 
These compounds have different modes of action: 
I. Tubulin binding agents:  Vincristine and vinblastine kill the cells by binding to tubulin, 
thereby preventing the assembly of the mitotic spindle during metaphase. This inhibits 
polymerisation of β-tubulin with α-tubulin and stops mitosis (Payne and Miles, 2008). Cell 
division becomes impossible and the cell dies. Docetaxel and paclitaxel also bind to tubulin 
(3-subunit) but rather than prevent assembly they stabilise and promote the assembly of 
microtubules. This promotes polymerisation (Nobili et al., 2009). 
II. Topoisomerase inhibitors: Topoisomerase inhibitors inhibit the unwinding of DNA, 
thereby preventing replication, repair and transcription (Boik, 2001). Plant-derived 
chemotherapy drugs that use this mechanism include campothecins (Irinotecan and 
Topotecan) and epidophyllotoxins (Etoposide and Tenoposide). Campothecins inhibit the 
activity of topoisomerase 1 by binding to the DNA-enzyme complex and prevents 










the other hand, bind to the DNA-topoisomerase 2 complex causing DNA strand breaks and 
consequently cell death. 
1.7 Plants used in this study 
1.7.1 Moringa oleifera 
Moringa oleifera is also known as the drumstick tree or horseradish tree.  It is a small to 
medium-sized rapidly growing tree that is widely cultivated in tropical areas. It is native to India 
and is found growing wild in the sub-Himalayan regions of northern India. It also flourishes in 
other regions of Asia, South America and tropical Africa (Pandey et al., 2012). In Kenya, it was 
introduced in the early 1900s by Asians building the railway as recorded in Mohammed Sadiq 
Cockar’s ‘Memoirs of the Mombasa to Kisumu Railway’ (Odee et al., 2001). It is found in the 
Coastal, Eastern and Western parts of the country. The tree belongs to the family Moringaceace 
with 13 other species but M.oleifera is the most widely cultivated of the family. Other species 
found in Kenya are Moringa stenopetala, Moringa arbonea, Moringa borziana, Moringa 
longituba, Moringa rivae and Moringa ruspoliana. 
 
Figure 1.14: The Moringa tree (Maiyo, 2012) 
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The Moringa tree has been referred to as the miracle tree because of its many uses, especially its 
use as herbal medicine and a source of food. This is due to the presence of phytochemicals, 
minerals and proteins in the plant. All parts of this tree are edible and are consumed in different 
ways. The plant is a rich source of nutrients as it contains high concentrations of vitamins A and 
C, calcium and iron. The leaves are used as animal feed, in biogas production, as manure and 
also as a biopesticide because of its antifungal activity (Wadhwa et al., 2013; Mishra et al., 
2011). The seeds are also used as fertilizer and in water purification and treatment (Emmanuel et 
al., 2011; Mangale et al., 2012). This is due to the active coagulating agent found in the seed and 
its antimicrobial activity. This attribute has led to efforts encouraging domestication by families 
in low income areas who do not have access to clean water. The many uses of the Moringa tree 
are listed in Table 1.4. 
Table 1.4: Traditional uses of different parts of the Moringa tree 
Part of plant Traditional use References 
Leaves Biogas production, manure, biopesticide, animal 
feed, hypocholesterolemic, wound healing, larvicidal 
Pandey et al., 2012; Wadhwa 
et al., 2013; Maria et 
al.,2011; Mishra et al.,2011; 
Kumbhare et al., 2012; 
Sholapur et al., 2013; Odee et 
  Bark Dye, abortifacient, antifungal, antibacterial Wadhwa et al., 2013; Mishra 
et al.,2011  
Root Diuretic, cardiac tonic, antiarthritic, abortifacient Pandey et al., 2012; 
Kumbhare et al., 2012; 
Sholapur et al., 2013 
Pods Antipyretic, treatment of diabetes, antihelmintic Wadhwa et al., 2012; Mishra 
et al., 2011 
Seeds Fertilizer, water purification, water treatment, oil 
used in salads, lubrication, biodiesel, antipyretic 
Pandey et al., 2012; Wadhwa 




Most rural communities in Kenya have poor access to healthcare thus rely on medicinal plants 
including Moringa. The species M.longituba and M.Ruspoliana are used in the treatment of 
abdominal pains, eye and throat infections and sexually transmitted diseases (Odee et al., 2001). 
Different parts of these plants have been reported to possess anti-tumour and antioxidant activity 
due to the presence of phenolic compounds (Kumbhare et al., 2012). 
1.7.1.1 Compounds previously isolated from Moringa oleifera 
The Moringa tree is rich in compounds containing simple sugars. The plant is also rich in nitrile 
glycosides and glucosinolates which have been isolated from the leaves, seeds and stem bark 
(Malabed and Noel, 2013). These groups of compounds are unique to the Moringaceae family. 
Other compounds isolated include vitamins, sterols and carotenes which the plant is rich in. 
These are listed in Table 1.5 below.  
Table 1.5: Compounds isolated from different vegetable parts of Moringa oleifera 
Part of plant Compound isolated References 
Leaf Β-sitosterol, Quercetin, Kaemferol, niazirin, 
niazirinin, niaziminin A, Niaziminin B, 
lutein, 4-[(4-O-acetyl-α-L--rhamnosyloxy) 
benzyl] isothiocyanate  
Ragasa et al., 2012; Pandey et 
al., 2012; Faizi et al., 1994; 
Pakade et al., 2013; Mishra et 
al., 2011; Wadhwa et al., 2012 
Stem bark Epilupeol, β-sitosterol, moringine, 
moringinine,  4-(alpha-L-
rhamnopyranosyloxy) benzyl glucosinolate 
Maria et al., 2011; Mishra et 
al., 2011; Pandey et al., 2012; 
Sholapur et al., 2013 
Seed β-sitosterol, β-sitosterol-3-O-β-D-
glucopyranoside, 4-(4’-O-acetyl-α-L-
rhamnosyloxy) benzyl isothiocyanate, 4-(α-L-
rhamnosyloxy) benzyl isothiocyanate. 
Ragasa et al., 2012; Oloduro 




1.7.2 Prunus africana  
Prunus africana, also known as the African cherry or red stinkwood, is an evergreen tree that 
grows in many parts of sub-Saharan Africa. It belongs to the genus Prunus and the family 
Rosaceae. It has a blackish brown rugged bark with a red brown inner surface. Other trees 
belonging to this family include Prunus turfosa, Prunus serotina, Prunus lusitanica and Prunus 
amygdalus (Kadu et al., 2012). It can be found in the regions extending from Cameroon to 
Madagascar and Ethiopia to South Africa. In Kenya it is found in the highland regions including 
Mt. Kenya, Mt. Elgon, Tugen Hills, and Aberdare Ranges (Gachie et al., 2012). 
1.7.2.1 Medicinal uses 
In Kenya, it is traditionally used to treat malaria, stomach ache, fever, breast cancer, prostate 
cancer, colorectal cancer, and bovine babesiosis. It is also used as an appetite stimulant (Gachie 
et al., 2012; Kareru et al., 2007). Its crude extract is used worldwide in the treatment of benign 
prostatic hyperplasia (BPH) commonly found in older men which can go on to become life 
threatening cancer (Gathumbi et al., 2000). This is achieved through the reduction of oedema 
and inflammation of the prostate. This has been attributed to the presence of phytosterols, 
especially β-sitosterol and pentacyclic triterpenes, in the plant extract (Stewart, 2003). 
Phytosterols in the plants have been reported to reduce vessel permeability, hence reducing 
inflammation which correlates to their reported anti-inflammatory activity (Kadu et al., 2012). 
This activity is further enhanced by the presence of pentacyclic triterpenes which also have been 
reported to have anti-inflammatory and immunostimulatory activity. The bark contains the 
highest concentration of phytosterols and triterpenes. Its use in the treatment of BPH, especially 
in Europe and the USA, has led to massive harvesting of the bark of this tree which is sold in 
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local and international markets for profit (Shenouda et al., 2007). Pharmaceutical companies in 
Europe and America are manufacturing drugs for prostate illnesses using the bark of Prunus 
africana as a raw material which has led in uncontrolled harvesting of the bark for export. Due to 
this overexploitation, the tree is currently facing extinction because of massive debarking (Figure 
1.15) and export overseas (World Conservation and Monitoring Center, 1998). 
 
Figure 1.15: Debarking of Prunus africana (http://www.worldagroforestry.org) 
 
Several important compounds have been isolated from Prunus species (Table 1.6). 
 
Table 1.6: Compounds isolated from Prunus africana 
Part of plant Compounds isolated References 
Leaves β-Sitosterol, β-sitosterol-3-O-
glucoside, n-docosanol,  
Kadu et al., 2012; Mugaka et 
al., 2013. 
Stem bark Sitosterol, sitosterol-3-O-
glucoside, n-docosanol, 
ursolic acid, ferulic acid, 
myristic acid, oleanolic acid, 
campesterol. 
Kadu et al., 2012; Catalano et 




1.8 Phytochemical studies  
Phytochemical studies involved the use of different analytical techniques in the purification and 
characterisation of plant natural compounds. Chromatographic techniques are used in the 
purification of compounds while spectroscopic techniques are used for characterization and 
structural elucidation of isolated compounds. Plant compounds are extracted as crude extracts 
using solvents with varying degrees of polarity. Solvents used for extraction from the less polar 
to the most polar are hexane, dichloromethane (DCM), ethyl acetate, and methanol (MeOH) 
which extracts certain secondary metabolites based on their polarity. Chromatographic 
techniques commonly used for separation and purification are column chromatography and thin- 
layer chromatography (TLC). Other chromatographic techniques used for identification are Gas 
Chromatography-Mass Spectrometry. When a pure compound has been obtained, different 
spectroscopic analyses are used to elucidate the structure and to characterize the compound. 
These include nuclear magnetic resonance (NMR), ultraviolet-visible spectroscopy (UV-Vis) and 
infra-red (IR) spectroscopy. These techniques were used to achieve objectives 1 and 2 of this 
research and are further discussed below. 
1.8.1 Chromatographic techniques. 
Chromatography is a method of separation that distributes and separates components of a 
mixture in a stationary and a mobile phase. The stationary phase usually used is silica gel, 
alumina or sephadex and the mobile phase can be a liquid (organic solvents) or an inert carrier 
gas. The components are carried by the mobile phase through a stationary phase and are 




1.8.1.1 Column chromatography 
In column chromatography, the stationary phase is packed in a glass column and the mobile 
phase passes through the stationary phase by moving down the column by gravity, thereby 
eluting different components of the mixture. Columns of different sizes are used depending on 
the amount of sample to be purified. The column is wet or dry packed with a stationary phase, 
commonly silica gel or sephadex LH20. Thereafter, the components to be separated are loaded 
onto the column and a suitable solvent system is added as the mobile phase to elute compounds. 
Solvents are used starting with the least polar (which elutes non-polar compounds) to the most 
polar (which elutes polar compounds). When using sephadex as the stationary phase only one 
polar solvent is used as separation is due to size and not polarity. This is used to purify polar 
compounds. Components that partition in the stationary phase stay longer in the column and are 
separated from those that are eluted in the mobile phase. 
     





1.8.1.2 Thin-layer chromatography (TLC) 
In thin-layer chromatography (TLC) the stationary phase (silica gel, alumina and cellulose) is 
supported on a flat surface that can be glass or aluminum. The components to be separated are 
spotted on the surface of the stationary phase and developed in a chromatography tank. The 
mobile phase moves through the chromatographic plate by capillary action, thereby separating 
the compounds. Compounds are separated depending on their interaction with the mobile phase, 
similar to column chromatography.  
Generally, fractions collected from column chromatography are spotted on a TLC plate and 
placed in a developing tank with an appropriate solvent system. Observation of the compounds is 
facilitated by viewing under a UV lamp and also with a spraying reagent. Compounds are 
identified based on their Rf values. A single spot, as shown in Figure 1.17, usually indicates a 
pure compound. 
 







1.8.1.3 Gas-chromatography-mass spectrometry (GC-MS) 
GC-MS is a combination of two techniques, gas chromatography and mass spectroscopy. It is 
extensively used in drug testing, identification of environmental contaminants and in 
phytochemistry where it has found application in metabolic fingerprinting of plants (Jung et al., 
2011). GC-MS is used for the separation of components in a mixture and gives a spectral output, 
which aids in structural elucidation and identification. The column is made of glass or stainless 
steel and houses the stationary phase which is made up of a polymer, mainly fused silica. The 
mobile phase is an inert gas e.g. helium, hydrogen, or nitrogen. The sample is injected into the 
column and is transported by the carrier gas through the stationary phase where different 
compounds interact differently with the stationary phase and are eluted at different times from 
the column (Figure 1.18). The time a compound takes to be eluted from the column is called the 
retention time. Different compounds have different retention times. Upon elution the compound 
goes into the ionisation chamber of the mass spectrometer and is bombarded by a string of 
electrons causing it to break into fragments forming a fragmentation pattern that is unique for 
every compound. Different compounds have different fragmentation patterns and this coupled 
with retention time acts as the fingerprint of a compound. GC-MS can be used to separate polar 
and non-polar components with high reproducibility (Lee et al., 2013). The combination of mass 
spectrometry in the presence of huge data libraries makes GC-MS an extremely efficient tool in 
separation with a powerful detection system. Weller (2012) referred to GC-MS as unrivalled in 












Figure 1.18: Schematic diagram of a GC-MS equipment 
1.8.2 Spectroscopic analysis 
1.8.2.1 Nuclear magnetic resonance (NMR) spectroscopy 
This is a spectroscopic technique for determining the molecular structure of organic compounds 
through the analysis and interpretation of the spectrum. It is used for analysing known and 
unknown compounds. All atoms have nuclei which are electrically charged. When the nuclei are 
exposed to a magnetic field, they shift from a lower energy level to a higher energy level and 
back, releasing energy. This energy transfer takes place at a wavelength that corresponds to a 
radio frequency and the computer displays this output as an NMR spectrum. The magnetic field 
on a nucleus is also affected by the magnetic field on a neighbouring nucleus, causing an effect 
known as coupling which leads to splitting of the signal into two or more peaks. The resonance 












atom would result in a higher frequency. This frequency is represented as a chemical shift in 
parts-per-million (ppm) on the NMR spectrum. Chemical shifts in 1H-NMR are in the range of 0-
12 ppm and 0-220 ppm for 13C-NMR. 
To elucidate the structure of a compound, 1D NMR (1H-NMR, 13C-NMR and DEPT 90/135) is 
carried out. To obtain additional information especially for complex spectra that are difficult to 
analyse, 2D NMR is carried out. This includes 1H-1H Correlation spectroscopy (COSY) which 
shows correlations between coupled protons, and Nuclear Overhauser Enhancement 
Spectroscopy (NOESY) which show correlations through space, Heteronuclear Multiple Bond 
Correlations (HMBC) that identify H-C coupling that occurs 2-3 bonds away, and Heteronuclear 
Single Quantum Coherence (HSQC) that identifies H-C bonding in a molecule. A disadvantage 
of this chemical structural analysis tool is its lack of sensitivity (Weller, 2012). 
1.8.2.2 Other spectroscopic techniques 
Ultraviolet-visible light spectrometry uses radiation to identify functional groups in organic 
compounds. In UV-Vis spectroscopy, UV light passes through the compound and energy from 
the light promotes the electron to a higher energy state. It works at a range of 200 nm to 800 nm. 
Light absorbing molecules in a compound are known as chromophores and the wavelength of 
maximum absorption of a compound depends on these chromophores. Different compounds 
absorb light at different wavelengths depending on their functional groups present, which aid in 
their identification. 
Infra-Red spectroscopy is a qualitative method of analyzing compounds that aid in the analysis 
of its structure and chemistry. This is accomplished through the recognition of characteristic 
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shapes and patterns that arise from bond vibration in organic compounds and by using this 
information together with other physico-chemical data of the sample obtained (Coates, 2000).  In 
IR spectroscopy, the compound is exposed to infra-red frequencies and some are absorbed by the 
compound. The frequency absorbed causes this energy to excite bond vibrations in the molecule 
to a higher energy state which will be different in different compounds. The amount of frequency 
not absorbed and passes through is measured as percentage transmittance.  
1.9 Cell culture  
Cell culture is the propagation of cells in vitro under conditions closely resembling that of an in 
vivo system. This is a vital tool in cellular and molecular biology and is used to study the normal 
cell physiology and biochemistry in vitro. Cell culture has found wide application in the study of 
the effects of drugs and cytotoxic compounds on specific cell types. It is indispensable in drug 
screening and development on a larger scale due to its reproducibility and consistency. It is also 
used in the manufacture of viral vaccines and in the production of biological products such as 
enzymes and hormones.  
In mammalian cell culture, the cells are commonly isolated from blood or soft tissue. This is 
done by enzymatic or mechanical means. Cells used are mostly immortalised cells, meaning they 
can replicate indefinitely. Immortalisation is achieved either through random mutation, e.g. in 
HeLa cell line or deliberate modification e.g. in the HEK293 cell line. Immortalisation enables 
the propagation of cells in vitro for an indefinite period. 
Culture conditions vary for each cell type. Cells require a suitable vessel containing  medium 
with sufficient nutrients (amino acids, carbohydrates, vitamins and minerals), growth factors and 
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hormones. Commonly used media in the lab include Dubelco’s Minimum Essential Medium 
(DMEM) and Eagle’s Minimum Essential Medium (EMEM) which are commercially available 
and are normally supplemented with glutamine, antibiotics viz. streptomycin and penicillin as 
well as serum. Prepared media must be refrigerated before use at 4 ºC. Strict adherence to aseptic 
techniques must be observed at all times. Generally, the cells are incubated at 37 ºC temperature 
in CO2 in a humidified incubator.  When cells reach confluency (Figure 1.19), they are usually 
sub-cultured/split into other vessels to keep them at the log phase of growth or alternatively 
suitably plated for cell culture assays. Adherent cells can be detached enzymatically using 
trypsin. At this point, they can be plated and the cell numbers determined using a cell counter or 
a hemacytometer. Thereafter, plant extracts, or other test compounds can be added at different 
concentrations. Cells can be stored for future use by freezing them in a cryoprotective reagent 
e.g. DMSO at -130 °C. Freezing of cells is normally done gradually with a 1 ºC drop in 
temperature till a temperature of -80 ºC, thereby preventing formation of ice crystals and cell 
damage (Phelan, 1998). 
 




1.9.1 Cell lines used in this study 
1.9.1.1 HEK293  
These are human embryonic kidney cells generated 30 years ago by exposure to the human 
adenovirus type 5 to the cells chromosome. This modification was carried out by Graham and his 
team in 1977 (Thomas and Smart, 2005). This cell line is mostly used in the production of 
recombinant proteins but is also suitable in drug discovery studies.  The greatest challenge in 
chemotherapy is non-selectivity of the drugs. Chemotherapy kills both cancer cells and normal 
actively dividing cells, including red and white blood cells. This may lead to adverse side effects 
including immunosuppression, which could cause severe infection, leading to death. It is thus 
very important to try and find selective drugs that kill cancer cells without killing normal healthy 
cells. In this study, HEK293 cell line has been used as the control non-cancer cell line.  
1.9.1.2 Caco-2  
This is a colorectal adenocarcinoma cell line obtained from a 72 year old male. Lifestyle and in 
particular, diet is the major risk factor for colorectal cancer. Other risk factors are genetics and 
old age (Hamilton et al., 2000). This is the third most commonly diagnosed cancer in the world 
with a higher occurrence in developed countries (Aggarwal et al., 2013). However, with the 
changing lifestyle, especially the adoption of western diet in developing countries, cases of 
people diagnosed with colorectal cancer have increased in recent years. The type of diet can 
either prevent or accelerate the incidence of colorectal cancer. This cell line is used as a model 




This is a hepatocellular carcinoma cell line obtained from a 15 year old adolescent. It has an 
epithelial morphology. It is an excellent transfection host and is widely used in studies involving 
Hepatitis B, hepatocellular carcinoma (HCC) and other liver disorders. It is hence indispensable 
in human liver cancer research and in drug delivery. Liver cancer is a leading cause of death 
worldwide, with the risk factors being the Hepatitis B (HBV) and Hepatitis C (HCV) viruses (El-
Serag, 2012). Other risk factors include obesity, alcohol consumption and aflatoxin B intake. 
Occurrence is higher in men mainly due to lifestyle differences as they are more exposed to risk 
factors like smoking and alcohol intake (El-Serag et al., 2010). The highest incidence of liver 
cancer is in southeast Asia and western and eastern Africa. This has been attributed to the intake 
of aflatoxin B in contaminated grain. The high prevalence of HIV in developing countries has 
also been thought to increase the incidence of HCV and HBV (Venook et al., 2010). In this 
study, the HepG2 cell line is used to study the effects of the plant compounds isolated on the 
cells in vitro as a model for liver cancer. 
1.9.2 In vitro anti-cancer screening 
In vitro anti-cancer screening has been used for a long time by researchers as a rapid tool in 
screening natural and synthetic compounds for drug development. It is a major approach for the 
search of potential anti-cancer agents (Houghton et al., 2007). Cellular assays are the most 
commonly used for in vitro cancer screening because they are inexpensive, simple and rapid 
(Atta-ur-Rahman et al., 2005). These assays provide a way of rapidly screening a large number 
of compounds for potential activity. In these assays the rate of cell growth is measured by the 
formation of a colour change which is directly proportional to the number of viable cells. There 
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are a number of cellular assays that can be used, but the two most commonly used in research for 
anti-cancer studies  are the Sulforhodamine B (SRB) and the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assays. These assays are very specific and, therefore are 
used often when studying the activity of plant compounds. In this study, we utilized the MTT 
assay in our cytotoxicity assessment of compounds isolated. 
1.9.2.1 MTT assay 
The MTT assay is used in many laboratories worldwide due to its efficiency and reproducibility 
(Rubinstein et al., 1990). The principle of this assay is based on the succinate-tetrazolium 
reductase pathway in the mitochondria of living cells (Salati et al., 2013). This assay measures 
the metabolic activity of cells by their ability to reduce the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) to formazan using the succinate-tetrazolium reductase system. 
Viable cells with intact mitochondria use oxidised substrates and coenzymes, including NADPH 
and NADH, which reduce the formazan salt from yellow to pink (Figure 1.20) (Vistica et al., 
1991). Cells at confluency are plated on 24, 48 or 96 well plates and are incubated for 24 hours 
to allow for adherence of the cells to the plate. The compounds or extracts to be studied are then 
added and the cells incubated for 48 hours. Thereafter, MTT is added and the cells incubated for 
4 hours. Formazan crystals accumulate in living cells. A suitable chemical such as DMSO is 
added after 4 hours to dissolves the formazan, producing a pink/violet colour which can be 






















Figure 1.20: Reduction of MTT to a pink formazan salt by cellular dehydrogenases  
 
IC50 value is the most commonly used parameter for measuring cytotoxicity in vitro. This is the 
inhibitory concentration described as the concentration at which the possible cytotoxic agent 
attains 50% death. We have represented our cytotoxicity results in form of IC50 values which 
were calculated on Microsoft Excel 2010TM. 
1.9.2.2 Acridine Orange/Ethidium Bromide (AO/EB) Apoptosis Assay 
Tumour cells escape apoptosis because of gene mutation that causes production of proteins that 
inhibit apoptosis. This inhibition is a known characteristic of cancer cell growth and metastasis 
(Jurisic and Bumbasirevic, 2008). Induction of apoptosis is thus used as an important indicator of 
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the ability of chemotherapeutic agents to inhibit tumour growth and progression (Darakshan and 
Ghanbari, 2013). Apoptotic cells can be examined under a fluorescence microscope by staining 
and studying morphological changes of the cells. Morphological features of apoptotic cells 
include cell shrinkage, condensed chromatin, and fragmentation of the nucleus (Sumathi et al., 
2013; Attari et al., 2009; Meshkini et al., 2009) 
The AO/EB assay is used to study apoptotic cells in vitro by means of fluorescence. Changes in 
cellular and nuclear morphology, characteristic of apoptosis, are studied under a fluorescent 
microscope (Elmore, 2007). The assay is both qualitative and quantitative. Acridine orange and 
ethidium bromide bind to DNA and RNA by intercalation between adjacent base pairs causing 
the helical structure to stretch. This binding enhances its fluorescence intensity (Nafisi et al., 
2006). Acridine orange stains live and dead cells while ethidium bromide stains dead cells only. 
Live cell appear green under the microscope and early apoptotic cells have a bright green 
nucleus due to chromatin condensation and nuclear fragmentation. Late apoptotic cells appear 
orange because of taking up ethidium bromide and necrotic cells will stain orange but with a 
normal nuclear morphology (Khasibhatla et al., 2006). The cells can be counted under the 
microscope and the apoptotic index calculated.  
1.10 Antioxidants 
Antioxidants are compounds that donate electrons to prevent electron loss from other compounds 
such as fatty acids and DNA to free radicals. They may also be referred to as free radical 
scavengers.  Free radicals, also known as reactive oxygen species (ROS) contain an uneven 
number of electrons and gain or lose an electron to other compounds, thereby making them free 
radicals. The generation of free radicals in the body leads to oxidative stress which may cause 
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diseases like cancer, cardiovascular diseases and aging (Boik, 2001). Free radicals damage 
cellular DNA which may result in cancer development. This occurs frequently in the cell but is 
generally repaired by cellular mechanisms 
ROS can be produced in different ways, including immune cell activity and cellular respiration. 
Environmental and social factors may also lead to the production of ROS e.g. smoking and 
radiation. The body has its own antioxidants like enzymes catalase and superoxide dismutase, 
but due to the continuous production of free radicals it must obtain enough antioxidant supply 
through the diet. Polyphenolic compounds, especially flavonoids, have been reported to possess 
high antioxidant activity (Khanduja and Bhardwaj, 2003) and are sometimes used as standards in 
antioxidant studies. These compounds are found in a wide variety of fruits and green leafy 
vegetables. 
1.10.1 Antioxidant assays 
The 2,2-diphenyl-β-picrylhydrazyl (DPPH) and the ferric reducing antioxidant potential (FRAP) 
assay are the two most commonly used methods of testing for antioxidant activity in vitro (Prior 
et al., 2005).  
The DPPH assay is a simple, inexpensive assay based on the reduction of DPPH, a stable free 
radical by test compounds. Antioxidants react with DPPH which becomes paired off in the 
presence of a hydrogen donor producing DPPH-H. DPPH which is deep purple in colour gives a 
strong absorption maximum at 517 nm and changes to a yellow colour upon reduction by a 
strong antioxidant (Figure 1.21). Some of the standards usually used in this test include trolox, 
ascorbic acid, uric acid and α-tocopherol. 
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                               DPPH (purple)                                                DPPH-H (yellow) 
Figure 1.21: Reduction of DPPH (purple) by antioxidants to DPPH-H (yellow). 
The level of decolourisation depends on the number of electrons donated (Rajesh and Natvar, 
2011). The absorbances obtained are used to calculate the percentage scavenging ability of a 
compound using the following equation: 
% scavenging = [Absorbance of control-Absorbance of sample/Absorbance of                              
control] *100 
1.11 Aim and objectives 
The main aim of this study was to conduct a phytochemical investigation of two plant species, 
namely Moringa oleifera and Prunus africana that are commonly used to treat cancer in Kenya 
and to further determine the biological activity of the isolated compounds with focus on anti-
cancer activity. The specific research objectives were: 
1. To extract and purify compounds from different parts of the plants by means of column 












2. To identify and characterize the compounds isolated using spectroscopic techniques viz. 
NMR, GC-MS, UV-Vis and IR. 
3. To test the antioxidant activity of isolated compounds using the DPPH method. 
4. To test the isolated compounds for cytotoxicity on selected mammalian cancer cell lines 
viz. HepG2, Caco-2 and non-cancer cell line HEK293. 
5. To study the apoptosis induction of the compounds isolated on selected cell lines using 
the acridine orange-ethidium bromide dual staining method. 
1.12 Outline of thesis 
This thesis is written in the format of two papers and is divided into four chapters. Chapter 1 is 
the introduction and literature survey. 
Chapter 2 is presented in the form of a research paper. The title of the paper is ‘Cytotoxicity, 
antioxidant and apoptosis studies of quercetin-3-O-glucoside and 4-(β-d-glucopyranosyl-1→4-α-
l-rhamnopyranosyloxy)-benzyl isothiocyanate from Moringa oleifera’ and it addresses objectives 
met from the study of the first plant Moringa oleifera. 
Chapter 3 is also presented in the form of a research paper. The title is ‘Phytochemistry profiling, 
cytotoxicity and apoptosis study of β-sitosterol-3-O-glucoside and β-amyrin from Prunus 
africana’ and addresses the objectives met, based on results from the study of the second plant 
Prunus africana. 
Lastly chapter 4 provides a summary of the discussion and concluding remarks based on the 
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Of all the potent anticancer drugs currently available in the market, over 60% of them are of 
natural origin. Moringa oleifera, from the family Moringaceae, is used as a source of vegetable 
and herbal medicine and in the treatment of various cancers in many African countries including 
Kenya. The present study involved the phytochemical analyses of the crude extracts of 
M.oleifera and biological activities (antioxidant, cytotoxicity and induction of apoptosis in vitro) 
of selected isolated compounds. The compounds isolated from the leaves and seeds of the plant 
were quercetin-3-O-glucoside, 4-(β-D-glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl 
isothiocyanate, lutein and β-sitosterol. Antioxidant activity of quercetin -3-O-glucoside was 
significant compared to that of the control while 4-(β-D-glucopyranosyl-1→4-α-L-
rhamnopyranosyloxy)-benzyl isothiocyanate showed moderate activity. The cytotoxicity of  4-
(β-D-glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate and quercetin-3-O-
glucoside were tested in three cell lines, viz. hepatocellular carcinoma (HepG2), colon carcinoma 
(Caco-2) and a non-cancer cell line, Human Embryonic Kidney (HEK293) using the MTT cell 
viability assay. Apoptosis studies were carried out using the acridine orange/ethidium bromide 
dual staining method. The compounds isolated showed selective in vitro cytotoxic and apoptotic 
activity against human cancer and non-cancer cell lines, respectively. Quercetin-3-O-glucoside 
showed significant cytotoxicity against the Caco-2 cell line with an IC50 of 79 μg mL-1 and 
moderate cytotoxicity against the HepG2 cell line with an IC50 of 150 μg mL-1 while 4-(β-D-
glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate showed significant 
cytotoxicity against the Caco-2 cell line and HepG2 cell line with an IC50 of 45 μg mL-1 and 60 
μg mL-1, respectively. Comparatively both compounds showed much lower cytotoxicity against 
the HEK293 cell line with IC50 values of 186 μg mL-1 and 224 μg mL-1, respectively.  
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2.1. Introduction 
Cancer is a leading cause of mortality worldwide with over 7.6 million deaths reported in 2008 
alone (American Cancer Society, 2011) and 7 out of 10 deaths occurring in low and middle-
income countries. Medicinal plants have been in use in many cultures around the world for 
thousands of years to cure and prevent several diseases, including cancer. In Kenya, the majority 
of the population in rural and urban areas use traditional medicine to treat illnesses ranging from 
stomach ache and HIV/AIDS to cancer (Wagate et al., 2008). Plants possess activity against 
several known diseases, mainly due to the presence of bioactive compounds. A large number of 
bioactive plant compounds have been isolated and are commercially available, with over 60% of 
them being employed as anti-cancer drugs. These include Vincristine and Vinblastine isolated 
from Catharanthus roseus and paclitaxel (Taxol) isolated from Taxus brevifolia (Cragg and 
Newman, 2005). 
Moringa oleifera, from the family Moringaceace, is a fast growing tree indigenous to India, and 
is believed to have been introduced to Kenya in the early 1900s by the Asians (Odee et al., 
2001). In Kenya, the Moringa tree is mainly used as a source of vegetable and herbal medicine 
leading to it often being referred to as the miracle tree because of its versatility. The plants 
nutritional and medicinal value is largely due to the presence of essential phytochemicals, 
minerals, proteins and vitamins. All parts of this tree are edible and are consumed in different 
ways. The plant is a rich source of nutrients, containing high concentrations of vitamins A and C, 
calcium and iron. The leaves are used as animal feed, in biogas production, as manure and also 
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as a biopesticide due to its antifungal activity (Wadhwa et al., 2013; Mishra et al., 2011). The 
seeds are used as fertilizer, and in water purification and treatment owing to the active 
coagulating agent found therein and due to its antimicrobial activity (Dalen et al., 2009; Gamila 
et al., 2007). The Moringa tree is the main source of medicine for some rural communities in 
Kenya. All parts of the plant are used in traditional medicine to treat a plethora of diseases 
including abdominal pains, eye, throat and skin infections, sexually transmitted diseases and 
cancer (Odee et al., 2001).  
Crude extracts of the leaves and seeds have been shown to possess cytotoxic and antioxidant 
activity (Mishra et al., 2011; Wadhwa et al., 2013; Pandey et al., 2012). Compounds previously 
isolated from this plant include phenolic compounds, nitrile glycosides, sterols and alkaloids. 
Apoptosis is a term coined by Kerr et al (1972) referring to programmed cell death. This process 
is defective in most cancers and is a valuable drug target in cancer research. Sreelatha et al 
(2011) studied the anti-proliferative activity of the Moringa leaf extract on human 
nasopharyngeal carcinoma (KB) cells and reported apoptosis as a possible cause of cell death.  
The antioxidant activity of the leaf extracts of this plant were reported to be comparable to those 
of reference antioxidants (Wadhwa et al., 2013). This is attributed to the presence of high 
quantities of flavonoids and other polyphenols in the leaves. Antioxidants are important 
scavengers of free-radicals that are the main cause of oxidative stress in the body. Oxidative 
stress is believed to contribute significantly to the causation of a number of diseases including 
cancer mainly through DNA damage (Chandra et al., 2000) and hence plays a major role in the 
pathophysiology of carcinomas (Fuchs-Tarlovsky, 2013). Flavonoids are polyphenolic 
compounds with potent free radical scavenging ability and their biological activity has been 
related to this activity (Kumbhare et al., 2012).  Strong antioxidants have been reported to cause 
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cell death in vitro and enhance the activity of chemotherapy drugs (Boik, 2001), causing 
improved patient remissions by reducing oxidative stress caused by conventional chemotherapy 
drugs. 
Novel approaches for cancer chemo-prevention and therapy are of great importance to overcome 
the challenges associated with modern chemotherapy. In this study, we isolated and identified 
compounds through chromatographic and spectroscopic techniques. Compounds of interest were 
tested for antioxidant, cytotoxic and apoptosis induction in cancer and non-cancer mammalian 
cell lines. Our research sought to identify compounds from M. oleifera with possible anticancer 
activity that would lead to the production of potential drug candidates. 
2.2 Materials and methods 
2.2.1 General experimental procedures 
The solvents used for extraction and chromatography were of analytical reagent grade and were 
supplied by either Sigma or Merck chemical companies. Silica gel was used for column 
chromatography and pre-coated aluminium plates for thin layer chromatography (TLC). Both 
procedures were conducted at room temperature. Compounds were visualized on TLC under UV 
light using a H2SO4 in methanol (MeOH) spray reagent. 1D (1H and 13C) and 2D (HMBC, HSQC 
and COSY) NMR spectra were recorded at 400 MHz or 600 MHz on a Bruker AVANCE III 
spectrometer with tetramethylsilane (TMS) as the internal standard. The IR spectra for 
identification of functional groups in the compound were obtained on a Perkin Elmer Spectrum 
100 FT-IR spectrometer with a universal ATR sampling accessory. UV spectra were obtained on 
a UV-Vis-NIR Shimadzu UV 3600 spectrophotometer. 
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The cell lines used were human cancer cell lines HepG2 (human hepatocellular carcinoma) and 
Caco-2 (human colon carcinoma) and HEK293 (human embryonic kidney) cells as the control. 
The HEK293 cells were obtained from the Anti-Viral Gene Therapy Unit, University of 
Witwatersrand, and the Caco-2 and HepG2 cells were purchased from Highveld Biological, 
Lyndhurst, South Africa. 
2.2.2 Plant material 
Fresh leaves, stems, bark and seeds were collected in Maseno, Kisumu County, Kenya. The plant 
was identified at the Kenya Forestry Research Institute (KEFRI). The plant material was air-
dried in the shade for 6 weeks and ground into a fine powder. 
2.2.3 Extraction and purification 
Dried and ground samples of leaves (643.24 g), bark (580.60 g) and seeds (372.89 g) were 
sequentially extracted with hexane, dichloromethane (DCM) and MeOH for 48 hours on an 
orbital shaker at room temperature. The collected extracts were concentrated in a rotary 
evaporator to obtain the crude extracts which were then subjected to column chromatography 
using silica gel (Merck Kieselgel 60, 0.063-0.200 mm, 70-230 mesh ASTM) as the stationary 
phase and different solvent systems as the mobile phase. Collected fractions were monitored by 
TLC. Prior to column chromatography, the aqueous MeOH extract (139.64 g) was further 
partitioned in triplicate with equal volumes (200 mL) of DCM and then ethyl acetate to produce 
a DCM fraction (21.87 g) and ethyl acetate fraction (9.12 g).  
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Fractions 123-142 (50 mL each) were obtained from the ethyl acetate fraction of the MeOH 
extract (9.12 g) of leaves after using a 95% ethyl acetate: 5% MeOH mobile phase was dried and 
further purified using sephadex LH 20 in a 1 cm column. After collecting 2 mL fractions using 
100% MeOH, compound 1a (293.46 mg) was obtained in fractions 20-28.  
Fractions 50-55 (50 mL) were obtained from the ethyl acetate fraction (1.86 g) of the MeOH 
extract (4.01 g) of seeds after using a 70% ethyl acetate: 30% methanol solvent system were 
combined and purified in sephadex LH 20 to yield compound 2a (22.56 mg). 
The DCM extract of leaves and bark showed similar TLC profiles. Therefore, they were 
combined (3.67 g), and subjected to column chromatography and eluted with a hexane: ethyl 
acetate (v/v) solvent system, starting with 100% hexane and stepped by 10% to100% ethyl 
acetate. Fractions (100 mL) were collected and fraction 75 collected at 30% hexane: 70% ethyl 
acetate was further purified in a 1 cm column resulting in the isolation of compound 3a (73.45 
mg).  
Compound 4a (29.14 mg) was obtained from the DCM fraction of the MeOH extract (21.87 g) of 
leaves eluted at 60% hexane: 40% ethyl acetate in fractions 55-63 after collecting 50 mL 
fractions. The combined fractions (1.80 g) were further purified to yield the pure compound.   
2.2.4 Cell culture 
The cells were grown to confluency in 25 cm2 tissue culture flasks in Eagle’s Minimum Essential 
Medium (EMEM) supplemented with glutamine, 10% fetal bovine serum and antibiotics (100 µg 
mL-1 penicillin, 100 μg mL-1 streptomycin). Cells at a seeding cell density of 1.8 x 105 cells per 
well were plated into a 48 well plate containing 200 µL of medium. The cells were then 
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incubated overnight at 37 °C in 5% CO2, after which the medium was removed and 200 µL fresh 
medium was added. The compounds were first dissolved in 20 % dimethylsulfoxide (DMSO) 
and further diluted with phosphate buffered saline (PBS) for the cytotoxicity assay. Compounds 
1a and 2a at concentrations of 20 µg mL-1, 40 µg mL-1, 60 µg mL-1 and 80 µg mL-1 were then 
added in triplicate to the cells and incubated for 48 hours at 37 °C.  
2.2.5 Cytotoxicity assay 
2.2.5.1 MTT assay 
This assay measures the metabolic activity of cells and their ability to reduce MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to formazan using the succinate-
tetrazolium reductase system (Mosman, 1983). After 48 hours of incubation with the test 
compounds (as in 2.4), the old medium was discarded and fresh medium added to the wells. 
Cells with no test compounds were used as positive controls (100% viability). Approximately, 
200 µL of MTT at 5 mg mL-1 in PBS was added to each well. The cells were incubated with the 
MTT solution for 4 hours at 37 °C, after which the medium and MTT were removed from the 
wells,\ and 200 µL of DMSO was added to each well to dissolve the formazan salt. The presence 
of the formazan salt is indicative of cell viability and upon addition of DMSO produces a purple 
solution, the absorbance of which was read in a Mindray 96A microplate reader at 570 nm. The 
absorbance is proportional to the number of viable cells in each well. The tests were carried out 
in triplicate and graphs that were generated were used to calculate the concentration at which 
50% cell death was achieved (IC50) using Microsoft Excel 2010 ™. 
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2.2.6 Apoptosis assay 
The Acridine Orange/Ethidium Bromide (AO/EB) dual staining method is a simple, inexpensive 
qualitative and quantitative method of studying cell apoptosis. Acridine orange is taken up by 
both viable and non-viable cells. It intercalates into the DNA making viable cells appear green 
under a fluorescent microscope. Conversely, ethidium bromide is only taken up by non-viable 
cells whose membrane integrity has been compromised making their nucleus to fluoresce bright 
orange (Bezabeh et al., 2001). Cells were seeded at a density of 1.2 x 105/well into a 24-well 
plate and incubated overnight to allow the cells to attach. Thereafter, compounds 1a and 2a were 
added to the cells at concentration of 20 μg mL-1 and incubated for 48 hours. The cells were then 
washed with PBS, and 10 μL of AO/EB dye (100 μg mL-1 acridine orange and 100 μg mL-1 
Ethidium bromide in PBS was added and cells left at room temperature for 5 minutes. The cells 
were then viewed under a fluorescence microscope (Olympus inverted fluorescence microscope 
with a CC12 fluorescent camera (excitation filter of 450-490 nm and a barrier filter of 520 nm) 
(Wirsam Scientific & Precision Eq. LTD, Johannesburg, South Africa) at X200 magnification 
and examined for morphological changes due to apoptosis.  The apoptotic index was calculated 
as shown below:  
Apoptotic index = number of apoptotic cells/ number of total cells counted   
2.2.7 Antioxidant activity 
The antioxidant activity of compounds 1a and 2a was determined using the DPPH assay. This 
assay measures the reducing ability of a compound on the stable free radical DPPH. Antioxidants 
reduce DPPH to DPPH-H by donating hydrogen atoms. The antioxidant activities of the 
compounds were compared to that of ascorbic acid as the standard. 
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Compounds 1a and 2a and standard ascorbic acid were prepared at concentrations of 20 μg mL-1, 
50 μg mL-1, 100 μg mL-1, 250 μg mL-1 and 500 μg mL-1. DPPH (0.01 M in MeOH) was added to 
the compounds in a 3:1 ratio. Methanol only was used as the blank. The solution was left in the 
dark for 30 minutes since DPPH decays in the presence of light. Absorbance was then read on a 
Biomate UV-Vis spectrometer at 517 nm. IC50 values were calculated on Microsoft Excel 
2010TM. IC50 value in this assay represented the concentration of the sample required to scavenge 
50% of DPPH radical. 
2.3 Results and Discussion 
In the present study phytochemical analysis of the plant led to isolation and purification of four 
compounds, two of which were tested further for their antioxidant, cytotoxic and apoptotic 
activities in the HepG2, Caco-2 and HEK293 cell lines.  
2.3.1 Phytochemistry  
2.3.1.1 Compounds isolated 
Quercetin-3-O-glucoside (1a): yellow powder; C21H20O12; UV λ max nm MeOH: 266, 361: 1H-
NMR (MeOH, 400 MHz): δ ppm  7.7 (1H, d, J=2.16 Hz H-2’), 7.59 (1H, dd, J=8.53 Hz J=2.26 
Hz, H-6’), 6.86 (1H, d, J=8.40 Hz, H-5’), 6.38 (1H, d, H, J=2.14 Hz, H-8), 6.20 (1H, d, J=2.11 
Hz, H-6), 5.24 (1H, d,  J=7.44 Hz, H-1’’), 3.34-3.95 (Glucoside).  13C NMR (MeOH, 400 MHz): 
δ 159.0 (C-2), 135.6 (C-3), 179.4 (C-4), 163.0 (C-5), 99.9 (C-6), 166.0 (C-7), 94.7 (C-8), 158.4 
(C-9), 123.0 (C-1’), 117.6 (C-2’), 145.9 (C-3’), 149.8 (C-4’), 116.0 (C-5’), 123.2 (C-6’), 104.3 
(C-1’’), 75.7 (C-2’’), 78.3 (C-3’’), 71.2 (C-4’’), 78.1 (C-5’’), 62.5 (C-6’’). 
4-(β-D-glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate (2a): light brown 
oily solid; C20H27NO10S; UV λ max nm MeOH: 222, 270:  1H-NMR (MeOH), 600 MHz): 7.38 
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(2H, d,  J=8.28 Hz), 7.08 (2H, d, J=8.57 Hz), α-rhamnose; 5.43 (1H, d, J=3.7 Hz, H-1’), 
4.13(1H, m, H-2’), 4.05(1H, m, H-3’), 3.38(1H, m, H-4’), 3.66(1H, m, H-5’),  1.26(3H, d, J=6.0 
Hz, H-6’), Glucose 5.42 (1H, d, J=2.3 Hz, H-1’’), 3.75(1H, m, H-2’’), 40.2-4.03(1H, m, H-3’’), 
3.46-3.48(1H, m, H-4’’), 3.80-3.84(1H, m, H-5’’), 3.68-3.72(1H, m, H-6’’).  13C-NMR (MeOH, 
600 MHz): δ 155.7 (C-1), 116.5 (C-2), 129.0 (C-3), 129.9 (C-4), 129.0 (C-5), 116.5 (C-6), 60.8 
(C-7), 92.2 (C-1’), 77.9 (C-2’), 72.4 (C-3’), 81.4 (C-4’), 69.2 (C-5’), 16.6 (C-6’), 98.5 (C-1’’), 
82.3 (C-2’’), 72.9 (C-3’’), 71.8 (C-4’’), 70.8 (C-5’’), 61.9 (C-6’’), 131.1 (N=C=S). 
β-Sitosterol (3a): white powder: C35H61O6; UV λ max nm MeOH: 234: 1H-NMR (CDCl3, 400 
MHz): 5.33 (1H, d, J=5.06 Hz, H-6), 3.53 (1H, m, H-3), 0.90 (3H, d, J=6.5 Hz, H-21) 0.84 (3H, 
s, H-29), 0.82 (3H, s, H-26)0.80 (3H, d, J=1.5 Hz, H-27), 0.65 (3H, s, H-18, H-19). 13 C NMR 
(CDCl3, 400 MHz): δ  37.1 (C-1), 31.5 (C-2), 71.7 (C-3), 42.2 (C-4), 140.6 (C-5), 121.6 (C-6), 
31.5 (C-7), 31.8 (C-8), 50.6 (C-9), 36.4 (C-10), 20.9 (C-11), 39.6 (C-12), 42.2 (C-13), 56.6(C-
14), 24.2 (C-15), 28.9 (C-16), 55.9(C-17), 11.7 (C-18), 19.2 (C-19), 36.0 (C-20), 18.6 (C-21), 
33.8 (C-22), 25.9 (C-23), 45.7 (C-24), 29.0 (C-25), 18.9 (C-26), 19.7 (C-27), 22.9 (C-28), 11.8 
(C-29). 
Lutein (4a): reddish solid: C40H56O2: UV λ max nm MeOH:  1H-NMR (CDCl3 400 MHz): 6.58-
6.62 (m, H-11, H-11’, H-15, H-15’), 6.35 (d, J=14.92 Hz, H-12, H-12’), 6.27 (m, H-14, H-14’), 
6.17 (m, H-8, H-10, H-10’), 6.13 (s, H-7, H-8), 5.55 (1H, s, H-11), 5.43 (dd, J=25.59, J=10.04, 
H-7’), 4.22 (1H, s, H-3’), 4.02 (1H, m, H-3), 2.39 (1H, m, H-6’), 2.03 (1H, m, H-4), 1.97 (s, H-
19, H-20, H-20’), 1.91 (s, H-19’), 1.63 (d, H-18, H-18’), 1.05 (s, H-16, H-17), 1.09 (s, H-16’), 
0.82 (s, H-17’).   13C NMR (CDCl3 , 400 MHz): 37.1 (C-1), 48.4 (C-2), 65.0 (C-3), 42.5 (C-4), 
126.1 (C-5), 137.9 (C-6), 125.5 (C-7), 138.5 (C-8), 135.6 (C-9), 131.3 (C-10), 124.9 (C-11), 
137.7 (C-12), 136.4 (C-13), 132.5 (C-14), 130.0 (C-15), 29.5 (C-16), 24.2 (C-17), 21.6 (C-18), 
16.0 (C-19), 12.8 (C-20), 34.0 (C-1’), 44.6 (C-2’), 65.9 (C-3’), 124.8 (C-4’), 137.7 (C-5’), 54.9 
(C-6’), 128.7 (C-7’), 137.7 (C-8’), 135.0 (C-9’), 130.8 (C-10’), 124.4 (C-11’), 137.5 (C-12’), 
136.4 (C-13’), 132.5 (C-14’), 130.0 (C-15’), 28.7 (C-16’), 24.2 (C-17’), 22.8 (C-18’), 13.1 (C-

































































4-(β-D-glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate (2a) 
Figure 2.1: Compounds 1a and 2a isolated from Moringa oleifera and tested for cytotoxic, 
antioxidant and apoptotic activity. 
2.3.1.2 Isolation of compound 1a 
Column chromatography of the methanol extract of the leaves yielded compound 1a which was 
isolated as a yellow powder (293.46 mg). The 1H-NMR and 13C-NMR spectra showed 
characteristic resonances for flavonols namely quercetin. From the 1H-NMR spectrum, 
resonances for the A-ring protons at δH 6.1 (H-6) and at δH 6.3 (H-8) that were meta-coupled 
were observed.  The B-ring proton that resonated at δH 7.5 (1H, dd, J=8.53, 2.26 Hz, H-6’) was 
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ortho coupled to the proton at δH 6.8 ppm (1H, d, J=8.40 Hz, H-5’) and meta coupled to the 
proton at δH 7.7 (1H, d, J=2.14 Hz, H-2’). The presence of the sugar moiety was confirmed by 
the presence of the anomeric proton resonating at δH 5.2 (1H, d, J=7.44 Hz, H-1’’) and 
resonances between δH 3.32-4.24.  In the DEPT experiment, the resonance at δC 62.5 for C-6’’ 
was shown to be a methylene indicating that the sugar is a glucose.  The [M]+ ion at m/z 465 is in 
agreement with the molecular formula C21H20O12 for quercetin-3-O-glucoside.  The IR spectrum 
showed characteristic absorption bands for the O-H group (3400–3100 cm-1), C=C group (1615 
cm-1), and C-O group (1150–1010 cm-1).  The UV-Vis spectrum showed two absorption bands, a 
strong one at 238 nm and a weaker one at 281 nm originating from the A and B rings.  The 
physical and spectroscopic data for compound 1a matched those published in literature (Kazuma 



































Figure 2.2: Important HMBC correlations of compound 1a 
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2.3.1.3 Isolation of compound 2a 
Compound 2a was isolated as light brown and oily with a mass of 22.56 mg. The 1H-NMR 
spectrum of compound 2a showed resonances for two ortho coupled aromatic protons at δH 7.08 
(2H, d, J=8.57 Hz, H-2,H-6) and δH 7.38 (2H, d, J=8.28 Hz, H-3,H-5) indicating a para-
substituted benzene ring. This was confirmed by the 13C-NMR data which showed resonances at 
δC 116.5, 129.0 for (C-2, C-6) and (C-3, C-5), respectively. Anomeric proton resonances at δH 
5.43 (H, d, J=3.75 Hz, H-1’) correlated with C-1’ (δC 92.2) and δH 5.42 (H, d, J=2.3 Hz, H-1’’) 
correlated with C-1’’ in the HSQC spectrum indicating the presence of 2 sugars.  Methyl 
doublets at δH 1.26 (3H, d, J=6.0 Hz, H-6’) was assigned to the proton at C6’ and confirmed one 
of the sugars to be a rhamnose.  The DEPT experiments showed the presence of three quaternary 
carbons resonating at δC 155.7, 129.1, and 131.1 which were assigned to C-1, C-4 and C=N, 
respectively. Two methylene carbons at δC 61.99 and δC 60.80 were assigned to C-6’’ and C-7, 
respectively.  HMBC correlations of H-1’ and C-1 showed that the rhamnose is attached at C-1 
and further indicated that the glycosidic linkage between glucose and rhamnose is at 4’ and 1’’.  
The IR spectrum showed characteristic bands at 1630-1510 cm-1, indicating the presence of the 
C=S and C=N bonds of the thiocarbonate linkage attached to C7. A broad absorption band at 
3307 cm-1 indicated the presence of hydroxyl groups (-OH) in the molecule. The [M]+ ion at m/z 
310 is in agreement with the molecular formula C20H27NO10S for 4-(β-d-glucopyranosyl-1→4-α-
l-rhamnopyranosyloxy)-benzyl isothiocyanate. This information was consistent with published 































Figure 2.3: Important HMBC correlations of compound 2a 
The DCM extract of the leaves and bark yielded compound 3a and its structure was further 
confirmed to be β-sitosterol, a ubiquitous plant sterol, by comparing spectroscopic data with that 
in literature (Ragasa et al., 2012). Compound 4a was obtained from the leaves of the plant and 
the structure was confirmed to be lutein by comparing spectroscopic data with that in literature 
(Eldahshan et al., 2013; Ragasa et al., 2012; Shotipruk et al., 2012).  
2.3.2 Antioxidant activity 
The antioxidant test showed that the compound with the highest antioxidant activity was 
quercetin-3-O-glucoside (1a) whose activity with an IC50 of 26.73 µg mL-1 which was slightly 
higher than that of the control (31.68 µg mL-1). Quercetin is a strong antioxidant and is 
commonly used as a standard in antioxidant assays. 4-(β-d-glucopyranosyl-1→4-α-l-
rhamnopyranosyloxy)-benzyl isothiocyanate (2a), showed moderate antioxidant activity with an 






Table 2.1: Radical scavenging activity and related IC50 values of compounds 1a and 2a against 
the standard, ascorbic acid. Data represented as mean ± SD (n=3). 
Concentration in μg mL-1 % Scavenging activity 
Ascorbic acid 1a 2a 







100  65.15±0.004 68.21±0.006 50.81±0.020 
50  59.92±0.004 53.80±0.001 52.90±0.090 
20  41.90±0.020 49.53±0.060 35.38±0.500 





Figure 2.4: Antioxidant activity of compounds 1a (quercetin-3-O-glucoside) and 2a (4-(β-d-
glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate) and ascorbic acid as 



















Concentration in μg mL-1  
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2.3.3 Cytotoxicity tests 
Table 2.2: IC50 Values of compounds 1a (quercetin-3-O-glucoside) and 2a (4-(β-d-
glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate) on HEK293, HepG2 and 



























CELL LINES IC50 VALUES (µg mL-1) 
1a 2a 
HEK293 186 224 
HepG2 150 60 






Figure 2.5: MTT cell viability assay of compounds 1a (quercetin-3-O-glucoside) and 2a (4-(β-d-
glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate) in HEK293, HepG2 and 
Caco-2 cells. Data represented as mean ±SD (n=3). Compound 2a showed significant 
cytotoxicity against cancer cell lines HepG2 and Caco-2 compared to compound 1a (p≤0.05). 
The cytotoxicity of compounds 1a (quercetin-3-O-glucoside) and 2a (4-(β-d-glucopyranosyl-
1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate) on the three cell lines, Caco-2, HepG2 
and HEK293 was carried out using the MTT assay. The results (Figure 2.5, Table 2.2) indicate 
that quercetin-3-O-glucoside showed selectivity but moderate cytotoxicity across all three cell 
lines. It was more cytotoxic to the Caco-2 cell line with an IC50 of 79 μg mL-1 when compared to 
the HepG2 cell line with an IC50 of 150 μg mL-1 but showed lower cytotoxicity in the control 
HEK293 with an IC50 of 186 μg mL-1. 4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-
benzyl isothiocyanate displayed the greatest cytotoxic activity in the Caco-2 cell line with an 
IC50 of 45 μg mL-1 but slightly lower in the HepG2 cell line with an IC50 of 60 μg mL-1. From the 
cytotoxicity studies it can be deduced that 4-(β-d-glucopyranosyl-1→4-α-l-



























very low cytotoxicity seen in the HEK293 non-cancer control cells (IC50 of 224 μg mL-1). 
Statistical analysis of the results using ANOVA with subsequent LSD post hoc test using SPSS 
ver. 20 showed 4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate 
having significantly higher activity across all concentrations as compared to quercetin-3-O-
glucoside. Moreover 4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl 
isothiocyanate had significant activity as compared to the control untreated cells on Caco-2 cell 
line. Both compounds displayed no significant activity against HEK293 cell lines at 95% 
confidence level, however 4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl 
isothiocyanate had significantly higher activity as compared to quercetin-3-O-glucoside on 
HepG2 cell line.  
2.3.4 Apoptosis assay 
Apoptosis studies were carried out to determine whether the isolated compounds induced 
apoptosis in the selected cell lines. We used the double staining method with acridine orange and 
ethidium bromide and detected the characteristic morphological changes in the cells due to 
apoptosis under a fluorescent microscope (Olympus). These changes include cell shrinkage, 
chromatin condensation, fragmentation of the nucleus and cell membrane blebbing. Viable cells 
fluoresce green under the microscope, early apoptotic cells a brighter green, late apoptotic cells 
orange with a condensed chromatin, and necrotic cells orange without condensed chromatin 
(Khasibhatla et al., 2006). Results of exposure of the cells lines to the compounds for 24 hours at 
a concentration of 10 μg mL-1 are shown in Figure 2.6. Compounds 1a (quercetin-3-O-glucoside) 
and 2a (4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate) were seen 
to induce apoptosis in all cell lines. Apoptotic features were clearly observed in these cells. 
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Apoptosis induction was selective as evidenced by the high apoptotic index in the cancer cells 
compared to the non-cancer cell line. The apoptotic index was much higher in all the control 
cells compared to cells treated with quercetin-3-O-glucoside and 4-(β-d-glucopyranosyl-1→4-α-
l-rhamnopyranosyloxy)-benzyl isothiocyanate as shown in Table 2.3 below. 
Table 2.3: Apoptotic index values of compounds 1a (quercetin-3-O-glucoside) and 2a (4-(β-d-
glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate) on HEK293, HepG2 and 
Caco-2 cell lines. 
 
CELL LINES APOPTOTIC INDEX 
Control Compound 1a Compound 2a 
HEK293 0.000 0.057 0.03 
HepG2 0.000 0.37 0.132 



































Figure 2.6: Induction of apoptosis by compounds 1a and 2a on HEK293, HepG2 and Caco-2 at a 
concentration of 10 µg mL-1. L=Live A=Apoptotic LA= Late apoptotic EA= Early apoptotic. 
Scale is given as 100 µm. 









Some synthetic drugs have their structure based on natural compounds or are synthetic 
derivatives of these compounds e.g. flavopiridol (Shoeb, 2006). In vitro cytotoxicity testing is a 
valuable tool for screening compounds with potential anti-cancer activity. In this study, we have 
correlated growth inhibition with induction of apoptosis. Crude extracts of the Moringa tree have 
been shown to possess cytotoxic and antioxidant activity (Charoensin, 2014; Singh et al., 2013). 
The high antioxidant activity of quercetin-3-O-glucoside is important in ridding the body of 
reactive oxygen species, thereby protecting DNA from damage and thus lowering mutation rates 
and occurrence of tumour cells. However when quercetin is used as an antioxidant it is then 
broken down and oxidised to quinone-type metabolites which have a pro-oxidant action that 
binds and fragments DNA (Russo et al., 2012) which would explain its apoptosis induction 
activity (Fig.2.6). Flavonoids have been reported to cause cell death and apoptosis in A549 
(human lung adenocarcinoma) cells by inducing transcription of p21, a tumour suppressor gene 
that is only activated in the presence of p53 which is inactivated in most tumours (Colic and 
Pavelic, 2000; Patil et al., 2010). Quercetin has been proposed to induce apoptosis via the 
intrinsic/mitochondrial pathway through the  inhibition of protein kinase B phosphorylation and 
survivin which are responsible for the  activation of caspases and down regulation of anti-
apoptotic proteins Bcl-2 and Mcl-1 (Kuno et al., 2012; Russo et al., 2012). 
4-(β-d-glucopyranosyl-1→4-α-l-rhamnopyranosyloxy)-benzyl isothiocyanate has been isolated 
once previously by Oluduro et al in 2012 and here we report the first evidence of its cytotoxic 
and apoptotic activity on mammalian cell lines to the best of our knowledge. This group of 
compounds is unique to the Moringa family and similar compounds are reported to possess 
cytotoxic activity in vitro and in vivo, and it was suggested that the isothiocyano group is an 
essential part of this activity (Guevara et al., 1999; Ragasa et al., 2012). Studies on 
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isothiocyanates report that these compounds inhibit cancer cell growth and induce apoptosis 
through different targets. Srivastava and Singh (2004) reported growth inhibition and apoptosis 
induction by benzyl isothiocyanate in animal models. They postulated that the apoptosis 
induction was due to down-regulation of Bcl-2 and up-regulation of Bax which are anti-apoptotic 
and pro-apoptotic proteins, respectively. Regulation of phase I and phase II enzymes which are 
implicated in cancer risk have also been proposed to be major mechanisms of action of 
isothiocyanates (Wu et al., 2009; Navarro et al., 2011). The aqueous extract of the Moringa leaf 
has been reported to induce apoptosis in vitro and this was attributed to the presence of a high 
concentration of the flavonoids quercetin and kaempferol in the leaves (Sreelatha et al., 2011).  
The compounds in this study showed a concentration dependent cytotoxicity against both HepG2 
and Caco-2 cell lines. They also displayed selective cytotoxicity on cancer cells versus normal 
cells with an IC50 of 186 µg mL-1 and 224 µg mL-1. 4-(β-d-glucopyranosyl-1→4-α-l-
rhamnopyranosyloxy)-benzyl isothiocyanate was the more active of the two compounds with an 
IC50 value of 45 µg mL-1 in the Caco-2 cell line. Both compounds were not well tolerated by the 
Caco-2 compared to the HepG2 cell lines. Apoptosis induction is an important indicator of the 
ability of chemotherapy drugs to induce death in tumour cells. The results suggest that one of the 
causes of cell death upon exposure to these compounds is apoptosis. β-sitosterol and lutein have 
been isolated previously from this plant and occur in a wide variety of plants. They have been 
widely studied for their anticancer and chemopreventative potential (Ragasa et al., 2014; Patil et 





Four compounds were isolated from M.oleifera namely quercetin-3-O-glucoside, 4-(β-D-
glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate, lutein and β-sitosterol.  
Two of these compounds were tested for antioxidant, cytotoxicity and apoptosis induction. 4-(β-
D-glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate and quercetin-3-O-
glucoside demonstrated varying degrees of cytotoxicity against two human cancer cell lines. 
Their cytotoxic selectivity to cancer cells in vitro warrants their future investigation as potential 
chemotherapeutic agents with fewer side effects than drugs currently in usage.  Future studies 
need to be undertaken to understand the mechanism of action of these compounds and their 
specific target at the molecular level with regards to induction of apoptosis. In vivo studies also 
need to be conducted to investigate their effect on solid tumours and also to evaluate the 
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Prunus africana is used traditionally in Kenya in the treatment of cancer and worldwide in the 
treatment of benign prostate hyperplasia. In this study, compounds from the leaves and bark of 
this plant were isolated and tested for their cytotoxicity and apoptosis induction in two human 
cancer cell lines viz. hepatocellular carcinoma (HepG2), colorectal carcinoma (Caco-2) cells and 
a non-cancer cell line, viz. embryonic kidney (HEK293) cells. GC-MS profiling of the extract 
was also conducted. Three compounds, viz. β-sitosterol, β-amyrin and β-sitosterol-3-O-glucoside 
were isolated and the cytotoxic activity of β-amyrin and β-sitosterol-3-O-glucoside on the 
HepG2, Caco-2 and HEK293 was determined using the MTT cell viability assay. Both 
compounds had significant cytotoxic activity towards the Caco-2 cell line with IC50 values of 81 
μg mL-1 and 54 μg mL-1 for β-amyrin and β-sitosterol-3-O-glucoside, respectively while low 
cytotoxicity was observed on HepG2 cell lines with IC50 values of 206 μg mL-1 and 251 μg mL-1 
for β-amyrin and β-sitosterol-3-O-glucoside, respectively.  Apoptosis induction in cells was 
studied using acridine orange/ethidium bromide dual staining. In both cases, the compounds 
tested demonstrated selective cytotoxicity towards cancer cells with high apoptosis indices in 
cells exposed to β-amyrin. Low IC50 values of 156 μg mL-1 and 937 μg mL-1 for β-amyrin and β-
sitosterol-3-O-glucoside, respectively, were observed in the HEK293 cell line. GC-MS profiling 
of the extracts showed the plant to be rich in phenolics, pentacyclic triterpenoids and sterols. 





3.1 Introduction  
Cancer is a leading cause of death in Africa with 70% of the deaths occurring in low and middle 
income countries in the continent. However, it is given low public health priority due to the 
burden of infectious diseases (Jamison et al., 2006). For the majority of the population in Africa, 
healthcare is inaccessible. Therefore, many people rely on herbal medicine for treatment, 
particularly with regards to chronic diseases. Medicinal plants are a source of affordable 
medicine for the majority of low-income earners in most parts of Africa and, furthermore, most 
of the locals and rural poor continue to rely on herbal medicine even with access to modern 
medicine (Kigen et al., 2013). 
Current cancer treatment proves to be challenging with chemotherapy drugs being non-specific 
and multi-drug resistance developing.  This results in chemotherapy related toxicities leading to 
patients succumbing to the adverse effects of the drug rather than the disease (Zhang et al., 
2011). Researchers are continually searching for alternative drugs that will overcome the 
challenges facing modern chemotherapy with bioprospecting being a viable route for the 
discovery of therapeutic agents. The success of natural products in cancer chemotherapy is well 
documented and has led to the development of drugs such as Taxol, from the Taxus brevifolia, 
and Maytansine from Maytenus serrata (developed using a monoclonal antibody as a targeting 
moiety which is currently in clinical trials) (Cragg and Newman, 2013).  
Prunus africana is an evergreen tree from the family Rosaceae. It grows widely in Africa, 
stretching from western to southern Africa. In Kenya, it grows in the wild in the highland regions 
of the country, but has also been domesticated by several communities (Gachie et al., 2012). P. 
africana is used traditionally for the treatment of colorectal, breast and skin cancer (Ochwang’i 
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et al., 2014). The bark and leaf extracts are also used to treat fevers, gonorrhea and stomach 
pains (Stewart, 2003a). 
Studies on P. africana have led to the isolation of sterols and pentacyclic triterpenes (Jimu, 
2011). The use of this plant has been attributed to the anti-inflammatory activity of the isolated 
compounds (Otieno et al., 2013). Extracts from the bark of P. africana are used worldwide in the 
treatment of benign prostate hyperplasia, which is an inflammation of the prostate gland mostly 
found in men over 50 years of age. The tree is also reported to contain ferulic acids, n-docosanol 
and n-tetracosanol which lower blood cholesterol levels (Stewart, 2003b). Prunus africana is 
currently facing extinction (World Conservation Monitoring Centre, 1998) owing to massive 
overharvesting for export where it is sold in the form of herbal formulations.  
Evidence and epidemiological studies suggest that phytosterols are protective against a wide 
range of diseases and possess anticancer activity on various cancers (Bradford and Awad, 2007).  
Few studies have documented the anticancer potential of this plant against different cancers. We 
herein report on the isolation and purification of three compounds, two of which were evaluated 
for cytotoxic activity on cancer cells, HepG2 and Caco-2 and for apoptosis induction as a 
possible form of death using immunofluorescent techniques. GC-MS profiling of the plant 




3.2 Materials and methods 
3.2.1 Materials 
Organic solvents (deuterated and undeuterated) and HPLC grade solvents were purchased from 
Sigma Co. (St. Louis, USA) and Merck (Darmstadt, Germany). Silica gel (Kieselgel 60, 0.063-
0.200 mm, 70-230 mesh ASTM), thin layer chromatography (TLC) aluminium backed plates 
pre-coated with silica gel and MTT salt (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium 
bromide) were bought from Merck (Darmstadt, Germany). Human embryonic kidney cells 
(HEK293) was obtained from the Antiviral Gene Therapy Unit, University of the Witwatersrand, 
while the hepatocellular carcinoma (HepG2) cells and colorectal adenocarcinoma (Caco-2) cells 
were purchased from Highveld Biological (PTY) LTD (Lyndhurst, South Africa). Eagle’s 
minimum essential medium (EMEM), penicillin/streptomycin and trypsin-EDTA, were 
purchased from Lonza BioWhittaker (Walkersville, USA). PBS was obtained from Calbiochem® 
(Canada). Foetal bovine serum was sourced from Hyclone GE Healthcare (Utah, USA). Acridine 
orange and ethidium bromide for apoptosis studies were obtained from Promega (Madison, 
USA). All other reagents were of analytical reagent grade.   
3.2.2 General experimental procedures 
Organic solvents hexane, dichloromethane (DCM) and methanol (MeOH) used for extraction 
and purification were distilled before use. Crude extracts were subjected to column 
chromatography, with silica gel as stationary phase, for purification. TLC was used to profile 
column fractions and spots were visualised under UV light and by use of an anisaldehyde spray 
reagent (20% H2SO4 and 80% MeOH). NMR spectra were obtained from a Bruker Avance 400 
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MHz or 600 MHz using TMS as an internal standard. The compounds were dissolved in 
deuterated solvents either chloroform (CDCl3) or dimethylsulfoxide (DMSO). Chemical shifts 
(δ) are expressed in ppm. UV spectra were obtained on a Perkin-Elmer Lambda 35 UV-Vis 
spectrophotometer using MeOH and hexane as solvents. Extract profiling was conducted on a 
GC-MS (Agilent GC-MSD equipped with a DB-5SIL MS fused silica capillary column) for 
identification of compounds. Extracts were dissolved using HPLC reagent grade solvents, MeOH 
and DCM. Phytocompounds were identified using the National Institute of Standards and 
Technology (NIST) database library.  
3.2.3 Plant material 
Samples of leaves and bark were collected from a traditional healer in Eldama Ravine Town (0º 
03’N 35º 43’E/0.05º N 35.72º E), Koibatek District in Baringo County, Kenya. The identity of 
the tree was confirmed by the Kenya Forest Research Institute (KEFRI). The leaves and bark 
were air-dried in the shade for 2 weeks and cut into smaller pieces. The plant material was 
ground into a fine powder and weighed. This yielded 674.52 g of leaves and 423.45 g of bark.  
3.2.4 Extraction and purification 
Sequential extraction of the ground leaves and bark with hexane, DCM and MeOH was carried 
out for 48 hours on an orbital shaker. Extracts were filtered using Whatman No. 1 filter paper 
and concentrated under vacuum in a Buchii rotary evaporator to obtain a viscous concentrate. 
This was weighed and stored at 4 ºC in a refrigerator. 
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Purification of compounds was achieved using column chromatography. The combined hexane 
and DCM extract of the leaves (157.17 g) was separated using a hexane: ethyl acetate solvent 
system starting with 100% hexane and stepped by 10% to 100% ethyl acetate. Ten 100 mL 
fractions were collected for each solvent system.  Fractions 37-40 was re-chromatographed to 
obtain compound 1b (112 mg) in fractions 13-17 using a hexane (85%): ethyl acetate (15%) 
solvent system (v/v) after collecting 20 mL fractions. Fraction 51-55 from the crude extract 
yielded compound 2b (23.9 mg).   
The aqueous MeOH extract of the plant was partitioned in triplicate with 200 mL DCM and 200 
mL ethyl acetate to obtain a DCM fraction (25 g) and ethyl acetate fraction (3.05 g). The DCM 
fraction obtained was subjected to column chromatography starting with 100% hexane and was 
stepped gradually with ethyl acetate. Fractions 92-103 (100 mL each), collected with hexane 
(10%): ethyl acetate (90%) (v/v) were pooled and further purified on sephadex LH20. MeOH 
(100%) was used to elute the compounds on a 1 cm column and 3 mL fractions were collected to 
obtain compound 3b (19.5 mg) in fraction 3.  
3.2.5 Extract profiling by GC-MS  
An investigation of the hexane and DCM extract of the leaves and bark was done by GC-MS 
analysis. The injection volume was 1.0 μL with an injector temperature of 25 °C. Helium was 
used as the carrier gas with a column flow of 1.0 mL min-1. The oven programme was 60 °C 
ramped to 260 °C at 4 °C min-1 for 10 minutes and held at 260 °C for 10 minutes. Total running 
time was 30 minutes. Hexane and DCM fractions collected using column chromatography were 




3.2.6 Cell culture 
The cancer cell lines HepG-2, and Caco-2 and the non-cancer cell line HEK293 were grown in 
EMEM+Glutamine medium supplemented with 10% FBS and 100 µg mL-1 penicillin and 100 µg 
mL-1 streptomycin. They were cultured and maintained in 25 cm2 culture flasks at 37 °C and 5% 
CO2. At 90% confluency, the cells were trypsinised by overlaying the cells with 1mL trypsin-
EDTA for 2 minutes. Once cells were trypsinised as evidenced by cells rounding off, fresh 
medium was added and the cells were split as desired or plated in 48 well plates for assay 
purposes.  
3.2.7 MTT cell viability assay 
This is one of the most widely used assays to measure cell viability. This assay measures the 
ability of viable cells to reduce MTT by mitochondrial dehydrogenases to the insoluble formazan 
salt. The salt once solubilised forms a pink/violet colour whose absorbance is measured 
spectrophotometrically (Mosman, 1983).  
In this study, cells were plated on a 48 well plate with 200 µL media at a seeding density of 1.2 × 
105 and incubated for 24 hours to allow attachment. Thereafter, the medium was changed and 10 
µL of the compounds dissolved in DMSO and further diluted with PBS were added to the cells at 
concentrations of 20 μg mL-1, 40 μg mL-1, 60 μg mL-1 and 80 μg mL-1 in triplicate and incubated 
for 48 hours. Approximately 200 µL of MTT at a concentration of 5 mg mL-1 in PBS was added 
and incubated for 4 hours at 37 °C. After four hours, the medium was removed from the wells, 
leaving the formazan salt at the bottom. Subsequently, 200 µL of DMSO was added to solubilise 
the salt producing a pink colour whose absorbance was measured on a Mindray MR-96A 
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microplate reader (Vacutec, Hamburg, Germany) at 570 nm. Cytotoxicity was represented as 
percentage cell survival against compound concentration. IC50 values were calculated from 
graphs of percentage inhibition against concentration in Microsoft ExcelTM. 
3.2.8 Apoptosis studies 
Dual staining with acridine orange and ethidium bromide is a rapid technique for studying cell 
apoptosis in vitro. It enables the distinguishing of live, late and early apoptotic and necrotic cells. 
Acridine orange stains live cells by intercalating with the cell’s DNA to emit green fluorescence, 
while the ethidium bromide stains dead cells emitting yellow to red fluorescence based on the 
stage of apoptosis. Approximately 100 mg mL-1 of both dyes was prepared in PBS. The dyes 
were mixed at a ratio of 1:1. Cells at a density of 1.2 × 105 were plated on 24 well plates and 20 
µL of each compound at 10 µg mL-1 was added to the cells and incubated for 24 hours. 
Subsequently, old medium was removed from the plate and the cells were washed with 100 µL 
cold PBS. Thereafter, 15 µL of the dye solution was added to the cells which were then viewed 
under an Olympus fluorescent microscope at ×200 magnification. Apoptotic indices were 
calculated as shown:  
Apoptotic index = number of apoptotic cells/ number of total cells counted 
3.3 Results and Discussion 
3.3.1 Phytochemistry 
NMR studies led to the confirmation of 3 major compounds i.e. β-sitosterol (1b), β-amyrin (2b) 
and β-sitosterol-3-O glucoside (3b). 
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3.3.1.1 Isolated compounds  
β-Sitosterol-3-O-glucoside (3b): white amorphous powder: C35H61O6: UV λ max nm MeOH: 204, 
233. 1H-NMR (DMSO, 400 MHz): δ 5.34 (1H, m, J=5.06 Hz, H-6), 4.86 (3H, dd, J=4.54 Hz, 
13.61 Hz, OH-2’, OH-3’, OH-4’), 4.41 (1H, t, J=5.64 Hz, 11.49 Hz, OH-6’), 4.24 (1H, d, J=7.70 
Hz, H-1’), 3.67 (1H, m, H-6’), 3.48 (1H, m, H-3), 3.14 (1H, dd, J = 3.72 Hz, J= 8.7 Hz, H-3’), 
3.10 (1H, m, H-5’), 3.08 (1H, m, H-4’), 2.92 (1H, m, H-2’), 2.16 (2H, m, H-4), 0.97 (1H, s, H-
19) 0.92 (1H, d, J = 6.74 Hz, H-21), 0.84 (1H, d, J = 6.83 Hz, H-27), 0.82 (1H, d, J = 7.10 Hz, 
H-26), 0.67 (1H, s, H-18). 13C-NMR (DMSO, 400 MHz): δ 36.7 (C-1), 29.2 (C-2), 77.4 (C-3), 
37.3 (C-4), 140.9 (C-5), 121.6 (C-6), 31.8 (C-7), 31.9 (C-8), 50.1 (C-9), (C-10) 20.1 (C-11), 38.8 
(C-12), 42.3 (C-13), 56.6 (C-14) 24.3 (C-15), 28.2 (C-16) 55.9 (C-17) 12.1 (C-18), 19.5 (C-19), 
(C-20), 19.1 (C-21), 33.3 (C-22), 25.9 (C-23), 45.6 (C-24), 28.6 (C-25), 19.4 (C-26), 21.0 (C-






































































Figure 3.1: Chemical structures of compounds 2b (β-amyrin) and 3b (β-Sitosterol-3-O-
glucoside) isolated from P. africana. 
3.3.1.2 Isolation of compound 2b 
Compound 2b was isolated as a white powder with a mass of 19.5 mg. The 1H-NMR spectrum of 
compound 2b showed characteristic resonances for a pentacyclic triterpene of the oleanane type. 
These were a downfield vinylic proton resonance at δH 5.25 (1H, t, J=6.6 Hz, 3.3 Hz, H-12), a 
carbinylic proton resonance at δH 3.20 (1H, dd, J=10.6 Hz, 4.1 Hz, H-3), a double doublet at δH 
2.81 (1H, dd, J=14.3 Hz, 4.4 Hz, H-18) and seven methyl resonances between δH 0.77-1.19 (s, 
H-23-H-30). The 13C-NMR spectrum showed resonances at δC 143.8 (C-13) and δC 122.2 (C-12) 
due to the vinylic carbons and a resonance at δC 78.8 (C-3) due to the carbinylic carbon. The 
DEPT 90 and 135 experiments resolved 8 methyl, 10 methylene, 5 methine and 7 quaternary 
carbon resonances.   
96 
 
The UV spectrum of compound 2b gave maximum wavelength (λ max) at 229 nm. The IR 
spectrum showed a broad absorption band at 3263 cm-1 (OH group) and a band at 1459 cm-1 
(C=C). GC-MS data showed molecular ion peak [M+] at m/z 426 which is in agreement with the 
molecular formula C30H50O. This data corresponded with that in literature (Mohato and Kundu, 
1994; Vasquez et al., 2012) and confirmed compound 2b to be β-amyrin.  
3.3.1.3 Isolation of compounds 1b and 3b 
Compound 1b was isolated as an amorphous white solid with a mass of 112 mg and compound 
3b was isolated as an amorphous white solid with a mass of 23.9 mg. The 1H-NMR spectra for 
both compounds showed characteristic resonances for β-sitosterol. These were resonances at δH 
5.34 (1H, t, J=5.1 Hz, H-6) for the olefinic proton and a resonance at δH 3.53 (1-H, m, H-3) due 
to the carbinylic proton. However, for compound 3b, the resonance at δH 4.24 (1H, d, J=7.7 Hz, 
H-1’) due to the anomeric proton indicated the presence of a glycosidic linkage. This was 
confirmed by resonances between δH 2.92-4.86 which were assigned to H-2’, H-3’, H-4’, H-5’ 
and H-6’ and the sugar identified as glucose.  
The 13C NMR spectrum for compound 1b resolved 29 carbon resonances and for compound 3b 
resolved 35 carbon resonances with characteristic olefinic resonances at δC 140.9 (C-5) and δC 
121.6 (C-6) in sitosterol. The resonance at δC 101.2 (C-1’) in compound 3b was assigned to the 
anomeric carbon due to HSQC correlations. HMBC experiments confirmed the attachment of the 
sugar at C-3 (Figure 2) and the methylene at δC 61.6 was assigned to C-6’ of the glucoside.  
The UV spectra of compounds 1b and 3b showed two bands at 204 nm (0.3538 Å) and 231 nm 
(0.0984 Å). The IR spectra showed a broad absorption band at 3382 cm-1 (OH group), 2920 cm-1 
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(CH groups) and 1461 cm-1 (C=C). GC-MS data for compound 1b showed molecular ion peak 
[M+] at m/z 414 which is in agreement with the molecular formula C29H50O. GC-MS data for 
compound 3b showed molecular ion peak [M+] at m/z 576, which is in agreement with the 
molecular formula C35H60O6. 
This data corresponded with that in literature (Arora and Kalia, 2013; Jayaprakasha et al., 2010) 
and confirmed compound 1b to be the aglycone β-sitosterol and compound 3b to be the 
glycoside, β-sitosterol-3-O-glucoside. 
3.3.2 GC-MS profiling 
GC-MS profiling led to the identification of 9 compounds using the NIST library. The 
fragmentation pattern, name, structure and retention time were compared to those of known 
compounds in the library. These are given in Table 3.1. 
 
Table 3.1: Compounds of interest identified by GC-MS in the hexane and DCM extract of P. 
africana leaves. 
Compound Molecular ion/base 
ion peak 
TR (min) Structure 
α-amyrin 426/218 10.7 
HO




























































3.3.3 MTT cell viability studies 
The MTT cell viability assay was used to study the cytotoxic effect of β-amyrin and β-Sitosterol-
3-O-glucoside in the two cancer cell lines HepG2 and Caco-2 and non-cancer cell line, HEK293. 
Compounds tested exhibited a dose dependent cytotoxicity on the cancer cell lines. Both 
compounds showed selective cytotoxicity to cancer cells as evidenced by the high IC50 values 
156 µg mL-1 and 937 µg mL-1 on the control non-cancer cell line. Significant cytotoxic activity 
was observed on Caco-2 cell lines on exposure to both compounds with IC50 values of 54 µg mL-
1 and 81 µg mL-1 for β-amyrin and β-Sitosterol-3-O-glucoside, respectively. Our results showed 
that β-Sitosterol-3-O-glucoside was more potent against Caco-2 cells than β-amyrin which is in 
agreement with previously published studies (Jayaprakasha et al., 2010). Statistical analysis 
carried out using ANOVA with subsequent LSD post hoc test revealed that both compounds had 
significantly different activity across all the concentrations with sitosterol-3-O-glucoside 
showing higher activity. However sitosterol-3-O-glucoside and β-amyrin compounds had no 
significant cytotoxic effect on HepG2 cells with IC50 values of 206 µg mL-1 and 251 µg mL-1, 
respectively at 95% confidence level. β-Sitosterol-3-O-glucoside exhibited significant 
cytotoxicity against Caco-2 cell line as compared to the control untreated cells. Statistical 
evaluation revealed low cytotoxicity of β-amyrin across all cell lines which is consistent with 
published reports on the weak anticancer activity of some pentacyclic triterpenes stating that 







Figure 3.2: MTT cell viability assay of β-amyrin and β-Sitosterol-3-O-glucoside on HEK293, 
HepG2, and Caco-2. Data is represented as mean ±SD (n=3). Greater cytotoxicity was observed 
















































Table 3.2: IC50 Values of β-amyrin and β-Sitosterol-3-O-glucoside on HEK293, HepG2 and 






IC50 values in mg mL-1 
HEK293 156 937 
HepG2 206 251 
Caco-2 81 54 
 
3.3.4 Apoptosis studies 
Apoptosis studies were conducted to investigate the ability of test compounds to induce 
apoptosis in the cancer cell lines. Dual staining with acridine orange and ethidium bromide is 
widely used in studying nuclear cell morphology in apoptotic cells. Examination of HepG2 and 
Caco-2 cell lines upon exposure of 10 µg mL-1 of each compound for 24 hours revealed that 
unlike the untreated controls, the treated cells showed features characteristic of apoptosis. Live 
cells appeared green, early apoptotic bright green or yellow and late apoptotic cells red/orange. 
Observed in treated cells was chromatin condensation, nuclear fragmentation and cell shrinkage, 
unlike the controls which had round homogenous nuclei. A significant reduction in viable cell 
numbers was also observed, suggesting that one of the causes of cell death was apoptosis. 
Apoptotic bodies were not observed in the non-cancer HEK293 cell line. Apoptosis indices were 
higher in cells treated with β-amyrin that those treated with β-Sitosterol-3-O-glucoside. 
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Table 3.3: Apoptotic index values of β-amyrin and β-Sitosterol-3-O-glucoside on HEK293, 
HepG2 and Caco-2 cell lines. 
 
CELL LINE Control β-amyrin β-Sitosterol-3-O-
 Apoptosis index 
HEK293 0.00 0.00 0.00 
HepG2 0.00 0.35 0.27 





Figure 3.3: Fluorescence images of cell treated for 24 hours with β-amyrin and β-Sitosterol-3-O-
glucoside at a concentration of 20 µg mL-1 showing induction of apoptosis on HEK293, HepG2 
and Caco-2 L=Live A=Apoptotic EA= Early apoptotic. Scale is given as 100 µm. 






In vitro cytotoxicity screening is a valuable tool in drug discovery and is used widely by 
researchers especially when bio-prospecting for potentially active cancer drugs. Triterpenes are 
compounds of great interest in drug discovery owing to their diverse structures and wide 
pharmacological applications. Diet has been implicated in the development of many cancers, 
including colorectal cancer (Woyengo et al., 2009). Phytosterols are found in most plants and 
have shown evidence of anticancer activity in several studies (Pegel, 1997; Bradford and Awad, 
2007; Jaiprakash et al., 2010). 
Jaiprakash and co-workers in 2010 tested the inhibition of colon cancer cell line HT-29 with 
sitosterol glucoside isolated from Citrus aurantium which demonstrated potent activity with an 
IC50 value of 40 µM. β-amyrin esters, previously studied, exhibited potent cytotoxic activity 
against HL-60 leukemia cells with IC50 values of 1.8 to 5 µM. These compounds also induced 
apoptosis by activating caspase 3 (Barros et al., 2011). In this study, we isolated one pentacyclic 
triterpene and further identified its structural isomer using GC-MS analysis. We also isolated two 
plant sterols and identified another two by GC-MS analysis.   
In our findings, β-Sitosterol-3-O-glucoside and β-amyrin demonstrated dose dependent 
cytotoxicity across all cell lines with low cytotoxicity observed on HEK293 and HepG2 cell 
lines. In both compounds, greater activity was observed on the colon cancer cell line Caco-2 
rather than the hepatocellular carcinoma cell line HepG2, with β-Sitosterol-3-O-glucoside 
showing slightly higher activity (IC50 54 mg mL-1) than β-amyrin (IC50 81 mg mL-1). 
Apoptosis is programmed cell death and is characterized by nuclear condensation and 
fragmentation, cell shrinkage, chromatin condensation and membrane blebbing (Hunter et al., 
2007). Apoptotic cells are eventually phagocytised in vivo by macrophages. Thus no 
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inflammation occurs. However, apoptotic cells cultured in vitro ultimately undergo secondary 
necrosis due to the absence of phagocytes. Impaired apoptosis through up or down regulation of 
apoptotic proteins is implicated in a number of diseases including autoimmune and 
neurodegenerative diseases and in this case cancer. Mutation and down regulation of p53 are 
reported in most cancers, including colon and liver cancer (Jaiprakash et al., 2010). The 
molecular players in apoptosis are the caspases and Bcl-2 family proteins which upon activation 
initiate apoptosis through the intrinsic or extrinsic pathway. Bax/Bcl-2 proteins ratio is an 
important indicator of how a cell will respond to apoptosis induction.  
To further investigate the influence of isolated compounds on apoptosis AO/EB, dual staining 
was conducted on the three cell lines upon exposure to test compounds. Both compounds tested 
induced apoptosis in Caco-2 cell line with high apoptosis indices of 0.33 and 0.13 compared to 
the control. Reduced cell numbers was also observed on this cell line on treatment with the two 
compounds. This was, however, not observed in HepG2 and HEK293 cell lines which both 
showed low apoptotic indices upon exposure to the compounds for 24 hours. This was in 
agreement with the studies done by Woyengo et al (2009) who reported apoptosis induction by 
β-sitosterol and Park et al (2007) who reported that β-sitosterol inhibited cellular proliferation 
and induced apoptosis in U937 leukemia cells by down regulation of the pro-apoptotic protein 
Bcl-2 and activation of caspase 3. This suggests that apoptosis induction by these compounds 
occurs via the intrinsic pathway. This has also been reported in stomach (Zhao et al., 2009) and 
colon cancer.  
GC-MS studies of P. africana led to the identification of a number of compounds some of which 
have reported anti-cancer activity. Triterpenes, phytosterols and phenolic compounds were 
identified in the hexane and DCM extracts by GC-MS. Vanillin, a widely used flavouring agent 
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was identified and this compound is also reported to successfully inhibit proliferation of HT-29 
colon cancer cells by inducing apoptosis (Ho et al., 2009). Studies on phytol, also identified in 
the extracts, report significant cytotoxicity on nasopharyngeal carcinoma (KB) cell line (23 µg 
mL-1) (Malek et al., 2009).  
3.4 Conclusion 
This study investigated the secondary metabolites of P. africana and their potential in cancer 
treatment by studying the in vitro cytotoxic and apoptotic activity on cancer cells. The 
pentacyclic triterpene, β-amyrin and a sterol, β-sitosterol with its glycoside, β-sitosterol-3-O-
glucoside were isolated from the leaves and bark of the plant. The MTT cell viability study of β-
amyrin and β-Sitosterol-3-O-glucoside showed β-sitosterol-3-O-glucoside to be the more active 
of the two compounds against the Caco-2 cell line. Both compounds were, however, inactive 
against the HepG2 cell line. Dual staining with ethidium bromide and acridine orange confirmed 
apoptosis induction as a mode of cell death with β-amyrin exhibiting higher apoptotic indices in 
both cancer cell lines than β-sitosterol-3-O-glucoside. The compounds tested showed selective 
cytotoxic and apoptotic activity as evidenced by the high IC50 values and low apoptotic indices 
on HEK293, the control non-cancer cell line. From the compounds isolated and those identified 
using GC-MS analysis, the plant appears to be rich in phenolics, pentacyclic triterpenes and 
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4.1 Overall summary 
4.1.1 Findings from Moringa oleifera 
Four pure compounds quercetin-3-O-glucoside (1a), 4-(β-D-glucopyranosyl-1→4-α-L-
rhamnopyranosyloxy)-benzyl isothiocyanate (2a), β-sitosterol (3a) and lutein (4a) were isolated 
from M. oleifera. Quercetin-3-O-glucoside and β-sitosterol were isolated from the leaves, bark 
and seeds, lutein from the leaves and 4-(β-D-glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-
benzyl isothiocyanate from the seeds. β-sitosterol and lutein have been studied widely and their 
biological activities, particularly anti-cancer potential, is well documented.  4-(β-D-
glucopyranosyl-1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate and quercetin-3-O-
glucoside were tested for their antioxidant activity using the DPPH assay and both compounds 
showed significant antioxidant activity with quercetin-3-O-glucoside showing higher activity 
than the standard ascorbic acid. This confirmed that the plant is a rich source of natural 
antioxidants.  Cell viability studies of quercetin-3-O-glucoside and 4-(β-D-glucopyranosyl-1→4-
α-L-rhamnopyranosyloxy)-benzyl isothiocyanate showed both compounds to exhibit selective 
cytotoxicity on the non-cancer cell line HEK293 with low IC50 values. 4-(β-D-glucopyranosyl-
1→4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate showed greater cytotoxicity across both 
cancer cell lines compared to quercetin-3-O-glucoside. A study of apoptosis induction as a 
possible cause of cell death in the three cell lines revealed apoptosis to be one of the causes of 
cell death with selectivity for cancer cell lines. 4-(β-D-glucopyranosyl-1→4-α-L-
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rhamnopyranosyloxy)-benzyl isothiocyanate has been isolated once before and, to the best of our 
knowledge, this is the first report of its cytotoxic and apoptosis activity on the three cell lines.  
4.1.2 Findings from Prunus africana 
Phytochemical studies on P. africana led to the isolation of three pentacyclic triterpenes: β-
sitosterol (1b), β-amyrin (2b) and β-sitosterol-3-O-glucoside (3b) from the leaves and bark. GC-
MS profiling of the hexane and DCM extracts of the leaves and bark led to the identification of 
several known pharmacologically active compounds. β-amyrin and sitosterol-3-O-glucoside 
were tested for their in vitro cytotoxic and apoptosis induction on two cancer cell lines. Both 
compounds showed moderate cytotoxic activity on the cancer cell lines. This plant species is 
facing extinction and has been declared endangered by the International Union for Conservation 
of Nature and Natural resources (IUCN) due to massive overharvesting of its bark for export. 
This study confirms that pharmacologically active compounds such as sterols and pentacyclic 
triterpenes in the bark are also present in the leaves. Therefore, the bark can be substituted with 
the leaves for treatment of BPH and cancer, thereby improving the conservation status of the 
plant.  
4.2 General conclusions 
The focus of this study was to conduct a phytochemical analysis and to evaluate the anti-cancer 
potential of two medicinal plant species, M. oleifera and P. africana, that are commonly used for 
treatment of cancer in Kenya. Herbal formulations concocted from these trees are currently taken 
orally or used topically to treat various cancers. The highly acclaimed anti-cancer activity by 
traditional healers led us to this study in an effort to produce a scientific basis for its use in 
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traditional medicine and also to source compounds that could be important future drug leads. To 
a great extent, the objectives of this study have been met.  Overall, the studied compounds 
showed varying degrees of anti-cancer activity to the cancer cell lines utilised. They have shown 
that they can be potential anti-cancer compounds and hence warrant further investigation. 
4.3 Recommendations for further study 
1. Further studies on the mechanism of action, especially with regards to apoptosis 
induction, should be carried out. Effects of isolated compounds on pro and anti-apoptotic 
proteins should be investigated. 
2. Studies on the safety, dosage and efficacy of plant extracts used as well as compounds 
tested should be investigated. 
3. Structural modification by addition of other functional groups to improve the activity of 
isolated compounds should be considered.  
4. In vivo antitumour studies of the active compounds reported in this work should be 
considered.  
5. Conservation measures of P. africana should be put in place by the Kenyan government 
by educating the public on the use of leaves instead of the bark in the preparation of 
herbal formulations. 
 
 
 
 
114 
 
APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
 
 
116 
 
 
117 
 
 
118 
 
 
119 
 
 
120 
 
 
121 
 
 
122 
 
 
123 
 
 
124 
 
 
125 
 
 
126 
 
 
127 
 
 
128 
 
 
129 
 
 
130 
 
 
131 
 
 
132 
 
 
133 
 
 
134 
 
 
135 
 
 
136 
 
 
137 
 
 
138 
 
 
139 
 
 
140 
 
 
141 
 
 
142 
 
 
143 
 
 
144 
 
 
145 
 
 
146 
 
 
147 
 
 
148 
 
 
149 
 
 
150 
 
 
151 
 
 
152 
 
 
153 
 
 
154 
 
 
155 
 
 
156 
 
 
157 
 
 
158 
 
 
159 
 
 
160 
 
 
161 
 
 
162 
 
 
163 
 
 
164 
 
 
165 
 
 
166 
 
 
167 
 
 
168 
 
 
169 
 
 
170 
 
 
171 
 
 
172 
 
 
173 
 
 
174 
 
 
175 
 
 
176 
 
 
177 
 
 
178 
 
 
179 
 
 
180 
 
 
181 
 
 
